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Probiotics and prebiotic are becoming increasingly important to consumers to 
alleviate issues surrounding gut health, despite the lack of definitive efficacy studies to 
support health claims. The addition of both probiotics and prebiotics to foods is 
challenging due to the harsh environmental conditions within the food itself and during 
transit through the gastrointestinal (GI) tract. To circumvent these challenges 
encapsulation technology is being explored to protect sensitive ingredients and to 
control their release within the lower intestines thereby maximizing the health benefiting 
effects. The overall goal of this research was to design a protein delivery capsule using 
phase separated pea protein isolate (PPI)-alginate (AL) mixtures for the entrapment of 
the synbiot which includes the probiotics, Bifidobacterium adolescentis, and the 
prebiotic, fructooligosaccharides (FOS), such that the capsule design provides highly 
effective protection and release within the GI tract. Research was carried out in three 
studies.  
  In study 1, PPIn (native isolate) and AL interactions were studied in dilute 
aqueous solutions as a function of pH and biopolymer mixing ratio. Turbidimetric 
analysis and electrophoretic mobility during an acid titration was used to determine 
conditions where phase separation occurred. Critical structure forming events associated 
with the formation of soluble and insoluble complexes in a 1:1 PPIn-AL mixture were 
found to occur at pH 5.00 and 2.98, respectively, with optimal interactions occurring at 
pH 2.10. As the PPIn-AL ratio increased, critical pH values shifted towards higher pH 
until a mixing ratio between 4:1 and 8:1was reached, above which structure formation 
became independent of the ratios through to ratios of 20:1. Electrophoretic mobility 
measurements showed a similar trend, where the isoelectric point (pI) shifted from pH 
4.00 (homogeneous PPIn) to pH 1.55 (1:1 PPIn-AL). As the ratio increased towards 8:1 
PPIn-AL, net neutrality values shifted to higher pHs (~3.80) before becoming constant at 
higher ratios. Maximum coacervate formation occurred at a mixing ratio of 4:1.  Based 
on these findings, capsule design by segregative phase separation was only used in 





 In study 2, capsule formation using a native and commercial PPI was studied, 
and showed no difference between the two formulations during challenge experiments 
in simulated gastric juice (SGJ). As a result study 3 focused on optimization and 
characterization of capsules prepared using the commercial PPI. Capsule designs were 
investigated as a function of protein concentration, prebiotic level, and extrusion 
conditions (20 vs. 27 G needle) in order to determine protective ability for B. 
adolescentis within SGJ. Capsule designs were also measured in terms of protein and 
prebiotic retention during the encapsulation process, geometric mean diameter and size 
distribution, swelling behaviour and release characteristics within simulated intestinal 
fluids (SIF). All capsules provided adequate protection over the 2 h duration within SGJ. 
Capsule breakdown and release was similar for all designs within SIF, with a release 
mechanism believed to be tied to enzymatic degradation of the PPI material within the 
wall matrix and/or the amount of excessive Na+ present in the SIF. Capsule size was 
found to be dependent only on the needle gauge used in the extrusion process. Swelling 
behaviour of the capsules with SGJ was also found to be dependent only on the protein 
concentration, where capsules shrank once immersed in SGJ.  
 A 2.0% PPI-0.5% AL capsule without FOS and extruded through a 20 G needle 
represents the best and most cost effective design for entrapping, protecting and 
delivering probiotic bacteria. Future work to establish the role FOS could play post-
release as the entrapping probiotics colonize the GI tract, and the protective effect of the 
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1.1 Summary  
 The overall goal of this research project is to design a novel protein-based 
delivery capsule using phase separated pea protein isolate-alginate mixtures for the 
entrapment of the synbiot which includes the probiotic, Bifidobacterium adolescentis, 
and prebiotic fructooligosaccharides (FOS), such that the capsule design provides 
sufficient protection against simulated gastric juice and release within simulated 
intestinal fluids.  
 A probiotic can be described as “a live microbial feed supplement which 
beneficially affects the host by improving its intestinal microbial balance” (Fuller, 
1989), if administered at therapeutic doses (107 live cells per gram of food) (Fooks et al., 
1999). Administration of probiotics have postulated health benefits, which include, 
alleviation of lactose intolerances, reduced risk of cancer, reduction of serum 
cholesterol, and prevention of intestinal tract infection (Gibson and Roberfroid, 1995b; 
Collins and Gibson, 1999; Shortt, 1999; Bielecka, 2007). However, once ingested the 
bacteria are exposed to barriers within the gastrointestinal tract including gastric and bile 
acids. These barriers cause only a small portion of probiotics to reach the colon intact 
and in a viable form. Also, once in the colon a bacteria population must become 
established and active, which may be difficult since the bacteria are most likely within a 
stressed state due to the exposure to gastric and bile acids, and must compete for 
nutrients and space against indigenous microflora. Prebiotics are defined as “a 
nondigestible food ingredient that beneficially affects the host by selectively stimulating 
the growth and/or activity of one or a limited number of bacteria in the colon, and thus 
improves host health” (Gibson and Roberfroid, 1995b). Functionally, prebiotics act to 
increase the number of beneficial bacteria which already colonize the colon. primarily 
from the Lactobacillus and Bifidobacterium genera (Farnworth, 2007). Some of the 
postulated health benefits prebiotics based on nondigestible oligosaccharides include, 
improved mineral absorption, resistance to invading pathogens, and regulation of lipid 





 To help circumvent challenges faced by probiotics within the food environment 
and during transit through the harsh conditions of the GI tract, many researchers are now 
employing encapsulation technology that protect the probiotics through the 
gastrointestinal tract yet release them in the small intestine at a targeted site (Chen et al., 
2005; Crittenden et al., 2006; Muthukumarasamy et al., 2006; Xiao Yan et al., 2009). 
The encapsulation technology involves encasing the sensitive core, probiotics, 
ingredient within a biopolymer shell, which can release its contents at controlled rates 
once triggered by an external sensor (e.g., temperature, pH, enzymes, etc.) (Dziezak, 
1988; Desai and Park, 2005; Anal and Singh, 2007). Although a wide variety of 
biopolymers have been employed as encapsulating agents, alginate-based capsules seem 
to dominate (Lee and Heo, 2000; Sultana et al., 2000; Chandramouli et al., 2004). 
Alginate is a linear heteropolysaccharide comprised of D-mannuronic and L-guluronic 
acids; the latter being highly sensitive to divalent calcium ions, resulting in the 
formation of strong egg box-like junction zones (Burey et al., 2008). However, alginate-
probiotic capsules have not adequately protected probiotic bacteria under SGJ (Lee and 
Heo, 2000; Sultana et al., 2000). The addition of proteins to the wall material can 
improve the survival of the probiotic bacteria through SGJ conditions due to a reduced 
pore size within the capsule, preventing the diffusion of SGJ into the capsules (Wood, 
2010).  
 Within the present research, probiotic capsules will be comprised of PPI-AL 
mixtures, using controlled phase separation as a means to alter the wall design to 
improve their survival under SGJ conditions and release within SIF. Phase separation 
within biopolymer mixtures is governed by biopolymer characteristics (e.g. size, type 
and distribution of reactive groups and the charge density), mixing ratio and 
concentration, and solvent conditions (e.g., pH, salt and temperature), and could result in 
either segregative or associative phase separation (Weinbreck et al., 2003a). The former 
case typically occurs under conditions where biopolymers carry similar net charges, for 
instance when an anionic polysaccharide and a protein (within solvent pH > isoelectric 
point, pI) both carry a net negative charge. Biopolymers tend to phase separate into a 
protein-rich and a polysaccharide-rich phase due to electrostatic repulsive forces. In the 





carry opposing net charges, such as an anionic polysaccharide and a protein (at pH < pI) 
resulting in the electrostatic attraction between the two biopolymers and phase 
separation into a biopolymer-rich (protein + polysaccharide) and a solvent-rich phase 
(Doublier et al., 2000; de Kruif et al., 2004). Encapsulation within biopolymer mixtures 
involving associative phase behaviour will give a capsule wall stabilized by electrostatic 
attractive forces, and will not require the need for chemical, enzymatic or salt cross-
links. However, in the case of encapsulation within biopolymer mixtures involving 
segregative phase behaviour, additional cross-linking agents will be required to maintain 
the wall integrity (e.g., calcium salts). 
 
1.2 Hypotheses 
 Research in this study focused on the following hypotheses: 
 associative phase separation between pea protein isolate and alginate mixtures will 
occur at solvent pH < pI of the protein and at pH > pKa of the carboxyl reactive site 
on the alginate polysaccharide, whereas segregative phase separation within the 
mixture will occur at solvent pH > pI of the protein; 
 biopolymer capsules will act to protect B. adolescentis within simulated gastric 
juice, and release its contents within simulated intestinal fluids; 
 the addition of fructooligosaccharides will improve the survival of B. adolescentis 
within the encapsulated wall; and 
 changes to the wall material and extrusion conditions will alter the physical 
properties of the capsule, its ability to protect B. adolescentis and to retain 




 To test these hypotheses, the following objectives were established: 
 to investigate the effect of pH and biopolymer mixing ratio on the phase behaviour 





 to develop encapsulation protocols for entrapping B. adolescentis within two 
capsules designs based on associative and segregative phase behaviour, testing their 
ability to offer protection with in simulated gastric juice; 
 to test various wall material ratio (e.g., biopolymer ratio and total concentration, and 
prebiotic concentration) and extrusion (e.g., needle gauge size) conditions; testing 
the impact on the physical properties of the capsules and on its ability to protect B. 
adolescentis; and 
 to test the release behaviour of B. adolescentis within the various capsule designs 





2.  Literature Review 
 
2.1 Probiotics 
Probiotics have been described as “a live microbial feed supplement which 
beneficially affects the host animal by improving its intestinal microbial balance” 
(Fuller, 1989). The Food and Agriculture Organization/World Health Organization 
(2001) more recently defined probiotics as “live microorganisms (bacteria or yeasts), 
which when ingested or locally applied in sufficient numbers confer one or more 
specified demonstrated health benefits for the host”. Probiotics reach the large intestine 
in an intact and viable form, therefore helping maintain the microbial balance in the gut 
(Gibson and Roberfroid, 1995b). For a microorganism to be classified as a probiotic it 
must: 1) be non-pathogenic; 2) be acid and bile tolerant; 3) withstand technological 
processes and remain viable during shelf life; and 4) demonstrate health benefits to the 
host (Gibson and Roberfroid, 1995b; Collins and Gibson, 1999; Shortt, 1999; Bielecka, 
2007). Typically, probiotics are associated with two main genera of lactic acid bacteria: 
Lactobacillus and Bifidobacterium (Gibson and Roberfroid, 1995b; Shortt, 1999). Other 
less common probiotic bacteria include Streptococcus, Leuconostoc, Pediococcus, 
Propionibacterium, and Bacillus. Some yeasts have also been classified to have 
probiotic effects such as Saccharomyces cerevisiae and S. boulardii (Fuller, 1992).  
Lactobacillus spp. are one of the most important microorganisms associated with 
the human gastrointestinal tract. They are gram positive, non-spore forming rods with 
anaerobic or microaerophilic respiration (Gomes and Malcata, 1999; Anal and Singh, 
2007). Gram positive bacteria have a thick peptidoglycan layer associated within their 
cell wall, whereas gram negative bacteria have a thin layer making the former more 
tolerant to environmental stresses (Madigan, 2003). Due to their anaerobic or 
microaerophilic respiration, growth occurs either in the absence of oxygen (i.e., 
anaerobic) or in an environment with a reduced concentration of oxygen of air (i.e., 
microaerophilic) (Madigan, 2003). These bacteria grow best at pH 5.5-6.0 and at 
temperatures of 35-40°C (Gomes and Malcata, 1999). Lactobacillus bacteria are 





probiotic on the market (Fuller, 1992). Common Lactobacillus spp. classified as 
probiotics include; Lactobacillus acidophilus, L. casei, L. delbruekii, and L. johnsonii 
(Gibson and Roberfroid, 1995b; Shortt, 1999). 
 Bifidobacterium were first isolated and characterized by Tissier in 1988 in feces 
of breast fed infants (Fuller, 1992; Gomes and Malcata, 1999). Bifidobacterium spp. are 
Gram positive, non-spore forming anaerobic bacteria (Gomes and Malcata, 1999; Anal 
and Singh, 2007). These bacteria grow best at 37-41°C and at pHs between 4.5-8.5, with 
optimal growth occurring between pH 6.0 and 7.0, and virtually no growth at pH <4.5. 
Bifidobacterium make up >95% of the intestinal microflora of infants with the 
predominant species being B. infantis and B. breve. Bifidobacterium populations are 
significantly reduced in adults and the predominant Bifidobacterium spp. are  B. 
adolescentis and B. longum (Fuller, 1992). Common Bifidobacterium spp. classified as 
probiotics are B. adolescentis, B. bifidum, B. longum, and B. animalis (Gibson and 
Roberfroid, 1995b; Shortt, 1999).  
 
2.1.1 Health benefits associated with probiotics 
 Presently, it is generally recognized that an optimum balance in the microbial 
flora within the digestive tract is associated with good health and nutrition (Lourens-
Hattingh and Viljoen, 2001). Increasing evidence suggests that consuming probiotics 
maintains this balance, leading to several postulated health benefits, such as:   
(a) Enhanced lactose absorption: Lactose malabsorption occurs when there is 
insufficient activity of lactase (β-galactosidase) in the human gut, resulting in a 
build-up of unabsorbed lactose (Fooks et al., 1999; Farnworth, 2007). Lactase 
functions to hydrolyze lactose into glucose and galactose units; allowing improved 
absorption through the intestinal wall. In contrast, a build-up of lactose creates 
abdominal distension, abdominal pain, excessive flatulence and/or diarrhoea. Some 
probiotic strains (e.g., Streptococcus thermophilus and Lactobacillus delbrueckii 
subsp. bulgaricus) found in fermented milk products (e.g., yogurt) are able to 





products (glucose and galactose), allowing the monosaccharides to be more 
efficiently digested (Fooks et al., 1999; Farnworth, 2007).  
(b) Prevention of intestinal tract infections: The addition of probiotics has also been 
shown to beneficially alter the gastrointestinal flora. By increasing the amount of 
beneficial bacteria, the resulting competitive exclusion protects the host against 
gastrointestinal infections caused by pathogenic bacteria (Bielecka, 2007). Gibson 
and Wang (1994b) found that eight different strains of Bifidobacteria (i.e., B. 
bifidum, B. adolescentis, B. angulatum, B. catenulatum,       B. breve, B. infantis, B. 
longum and B. pseudolongum) were able to excrete antimicrobials that inhibited the 
growth of pathogenic bacteria such as Vibrio cholera, Shigella sonnei, Listeria 
monocytogenes, E. coli, Campylobacter spp., Salmonella spp., Clostridium 
perfringens and Bacteroides fragile.  
(c) Reduced serum cholesterol: Fermented dairy products containing probiotic 
bacteria has been reported to reduce plasma cholesterol levels in humans. Although, 
there is no conclusive results, studies suggest the potential to use probiotics to lower 
total or low density lipoprotein cholesterol (Fooks et al., 1999). A high level of 
serum total cholesterol is generally considered to be a risk factor for coronary heart 
disease and atherosclerosis (Xiao et al., 2003). A study conducted by Xiao et al. 
(2003) investigated the ability of a low fat drinking yogurt supplemented with the 
probiotic, Bifidobacterium longum to lower the serum total cholesterol in 32 male 
volunteers with total serum cholesterol ranging from 220-280 mg/dL. They reported 
that after 4 wks of ingesting 3 x 100 mL/d there was a significant reduction in serum 
total cholesterol in subjects with moderate hypercholesterolemia. Schaafsma and co-
workers (1998) also investigated the effect of milk products fermented by L. 
acidophilus on blood lipid profiles in adult males; reporting that a daily feeding of 
125 mL probiotic milk significantly lower serum low density lipoprotein cholesterol 
levels.  
(d) Reduced risks of cancer: The ability of fermented yogurt products containing 
probiotics to reduce the risk of cancer is not well established. However, some studies 





(1994) used rat models to test the ability for B. longum to suppress the development 
of azoxymethane-induced preneoplastic lesions (e.g., aberrant cryptic foci which is 
associated with colon cancer). The authors found that feeding rats B. longum 
significantly suppressed the formation of aberrant cryptic foci, and could be used as 
a preventative treatment. A clinical study by Goldin and Gorback (1984) showed L. 
acidophilus, impacted on three bacterial enzymes, which catalyzed the conversion of 
procarcinogens to carcinogens. Over a 4-wk feeding trial with the milk 
supplemented with viable L. acidophilus, they reported a 2 to 4-fold reduction in 
bacterial enzyme activities (i.e., for β-glucuronidase, nitroreductase, and 
azoreductase). Other studies have also reported anti-carcinogenic activity with the 
use of probiotics in both human and animal models (Benno and Mitsuoka, 1992; 
Reddy, 1998; Rowland et al., 1998). 
The ability for probiotics to improve gastrointestinal health and to act as a preventative 
treatment remains promising. The Health Canada (2009) suggests that a product must 
contain 109 colony forming units (CFU) of probiotics per serving size to offer any sort of 
health benefit. As an example, a 100 g serving of yogurt containing 107 CFU/g would 
supply a sufficient amount. Although there are many claims associated with probiotics, 
there is no conclusive evidence of their benefits and, as such, research efforts are 
shifting towards efficacy issues.   
 
2.1.2 Challenges associated with the use of probiotics 
There are a number of challenges associated with the use of probiotics as 
preventative treatments, such as: 
(a) Exposure to harsh conditions within the gastrointestinal tract: The most 
common form of probiotic administration is through the direct addition of the 
probiotic agents to fermented milk products. However, once ingested, the bacteria 
are exposed to barriers in the gastrointestinal tract (e.g., gastric juice and bile acids) 
during transit, resulting in only a portion of probiotics reaching the colon intact and 
viable. Once in the colon, probiotics must colonize and become active which may be 





space with indigenous microflora (Gibson and Roberfroid, 1995b; Bezkorovainy, 
2001). Furthermore, the low pH of the stomach (pH 1.0-3.0) can also negatively 
impact the level of viable bacteria reaching the colon. Marteau et al. (1997) 
investigated the viability of probiotic bacteria (L. bulgaricus, Streptococcus 
thermophilus, L. acidophilus, and B. bifidum) when exposed to stomach pH and bile 
using a dynamic model of the stomach and small intestine. The authors indicated 
that after exposure to the gastric compartment (110 min) two of the bacterial strains, 
L. bulgaricus, and Streptococcus thermophilus had viability counts of <1%, while 
for L. acidophilus and B. bifidum the viability counts were 60% and 80%, 
respectively. The authors also exposed the bacteria to bile conditions, reporting 
viable counts prior to reaching the colon of <10% for L. bulgaricus and 
Streptococcus thermophilus, 15% for L. acidophilus, and 30% for B. bifidum. In 
another study, B. adolescentis, B. breve, B. lactis and B. longum cells were exposed 
to simulated gastric juice at pH 2.0 for 30 min, after which all strains were reduced 
by 5 log CFU/mL from the initial cell counts of ~8 log CFU/mL (Hansen et al., 
2002). The sensitivity of probiotic bacteria to acid and bile salts varies with each 
individual strain and creates a challenge to deliver sufficient viable cells to the 
colon. These results suggest that probiotics must be protected in some fashion in 
order to deliver sufficient numbers to the colon and exert a beneficial effect. 
(b) Adhesion to the intestinal wall: The ability for probiotic bacteria to adhere to the 
intestinal wall is essential in order to exert beneficial effects and survive within the 
colon. Bouhnik et al. (1992) investigated the fate of orally administered 
Bifidobacterium spp. in the gut. These studies demonstrated that the rate of recovery 
of Bifidobacterium spp. (approximately 30%) in the feces of human volunteers was 
found to be consistent with the amount able to survive passage to the colon, 
suggesting that the bacteria was not adhering to the intestinal wall. They reported 
that once the administration of the probiotic bacteria ended, the presence in the feces 
also ceased.  
(c) Processing and storage conditions: Viability of probiotics agents can also be 
reduced during product processing and storage (Mattila-Sandholm et al., 2002). 





bifidum claimed to be in five commercial yogurt products. They reported three out of 
the five products contained initial cell counts of < 105 CFU/g of L. acidophilus and 
two of the products with < 103 CFU/g of   B. bifidum. In the yogurt products tested, a 
50% decline in L. acidophilus viability after 20 d stored at 4°C occurred in two of 
the products; whereas a rapid decline in B. bifidum was observed in all products.  
Challenges associated with probiotics can be overcome through: 1) careful strain 
screening to find a more resilient probiotic; 2) the addition of prebiotic material to 
enhance growth and viability of the microorganisms; and 3) entrapment technology 
which involves encasing the probiotics within a protective biopolymer shell. 
 
2.2 Prebiotics 
Prebiotics are defined as “a non-digestible food ingredient that beneficially 
affects the host by selectively stimulating the growth and/or activity of one or a limited 
number of bacteria in the colon, and thus improves host health” (Gibson and Roberfroid, 
1995b). Prebiotics include food ingredients which pass through the upper part of the 
digestive system without being absorbed or hydrolyzed by human enzymes. These 
materials act as nutrients for endogenous colonic bacteria and therefore indirectly 
provide the host with energy, metabolic substances (short chain fatty acids), and 
essential micronutrients. For materials to be classified as prebiotic in nature, they must: 
1) reach the colon by resisting gastric acidity, hydrolysis by mammalian enzymes, and 
absorption in the stomach or small intestine; 2) be fermented by intestinal microflora; 
and 3) selectively stimulate the growth and/or activity of bacteria which promote health 
(Roberfroid, 2007; Sarkar, 2007). Functionally, prebiotics act to increase the number of 
beneficial bacteria which already colonize the colon, primarily from the Lactobacillus 
and Bifidobacterium genera (Farnworth, 2007).  
 
2.2.1 Sources of prebiotics 
The most common prebiotic source are non-digestible carbohydrates because 
they are naturally occurring, abundant, and meet all the criteria for prebiotic. Non-





intestine), non-starch polysaccharides (i.e., hemicelluloses, pectin, and gums), and non-
digestible oligosaccharides (i.e., inulin, fructo-oligosaccharides). 
Oligosaccharides are defined as carbohydrates with low degrees of 
polymerization (DP) (i.e., 2 to 10-20 monosaccharide units) (Roberfroid and Slavin, 
2000; Mussatto and Mancilha, 2007). Oligosaccharides are water soluble and instil a 
mild sweetness when in solution. Dextrose equivalent values for oligosaccharides range 
between 0.3-0.6 depending upon the composition and structure (Crittenden and Playne, 
1996). Due to the inability of humans to digest many oligosaccharides they are 
commonly used in low-calorie and diabetic foods. Oligosaccharides are typically 
produced using three different methods: 1) hot water extraction of roots (i.e., inulin 
extracted from chicory or Jerusalem artichoke); 2) enzymatic hydrolysis of 
oligosaccharides or polysaccharides (i.e., oligofructose produced from partial hydrolysis 
of inulin with endoinulinase); and 3) enzymatic synthesis from one or a mixture of 
monosaccharides by osyl-transferase (i.e., fructooligosaccharides (FOS) from sucrose) 
(Roberfroid and Slavin, 2000). A summary of the physicochemical properties of 
selected prebiotic materials is as follows:  
(a) Fructooligosaccharides 
Fructans such as inulin represent the most studied prebiotic material. Inulin is a 
linear chain of fructofuranose residues linked by β-(2→1) linkages (Figure 2.1). A 
terminal glucopyranosyl residue may be linked in the β-(1→2) configuration, as in 
sucrose on some of the chains, giving it a non-reducing end. Due to the β-configuration, 
fructans resist hydrolysis by mammalian enzymes which are specific to α–glycosidic 
bonds (Mussatto and Mancilha, 2007; Rastall, 2007; Roberfroid, 2007). Commercial 
inulin is produced from chicory root. Chicory inulin is composed of a mixture of 
oligosaccharides and polysaccharides, with DP ranging between 2 and ~60 units (DPav = 
12). Approximately 10% of the fructans in native chicory inulin have a DP ranging 
between 2 and 5 (Rastall, 2007; Roberfroid, 2007).  
Fructooligosaccharides (FOS) are the most extensively studied prebiotic as they 
meet all the prebiotic criteria. FOS is produced from the partial hydrolysis of inulin 
through the use of endoinulinase and is mainly constituted of oligosaccharides of D-














Figure 2.1 Chemical structure of a) 1-kestose (GF2), b) nystose (GF3) and                                  






FOS can also be produced via enzymatic synthesis (transfructosylation) using β-
fructosidase to add fructose to sucrose forming β-(2→1) linkages. The DP ranges from 2 
to 4 with a DPav = 3.6 (Rastall, 2007; Roberfroid, 2007). Production of FOS via 
transfructosylation leads to mixtures of oligosaccharides with terminal D-glucose (GFn) 
(Bañuelos et al., 2008). The main FOS are 1-kestose (GF2), nystose (GF3), and 
fructosylnystose (GF4) (Figure 2.1) (Bornet, 2001). Inulin and FOS are fermented by 
Bifidobacterium spp. and to a lesser extent by Lactobacillus spp. The growth of 
Bifidobacteria on these substrates is at the expense of potential pathogenic bacteria 
(Gibson and Roberfroid, 1995b; Rastall, 2007).  
Gibson and Wang (1994a) tested the ability of eight Bifidobacterium spp., B. 
infantis, B. catenulatum, B. longum, B. pseudomlongum, B. breve, B. anulatum, and B. 
adolescentis to grow on branched FOS (DPav=13, 8% branching), linear FOS (DPav = 4), 
inulin (DPav = 10), and glucose. They reported that seven of the species grew well with 
all the fructans tested, but generally the preferred growth substrate was short chain linear 
oligofructose (DP = 4). Bielecka et al. (2002) revealed subspecies belonging to B. 
longum and B. animalis had increased growth rates when grown in media containing 
1.0% (w/v) FOS (DP = 2-4) and Rafilose™ (DP = 2-8, glucose + fructose + lactose < 
6.8%) compared to inulin sources. Langlands and coworkers (2004) investigated the 
effects of a diet supplemented with an inulin/fructooligosaccharide mixture (7.5 g/d 
inulin, DPav = 10; 7.5 g/day fructooligosaccharide, DP = 2-8, glucose + fructose + 
lactose < 6.8%) for 2 wks  on 14 volunteers who were on the waiting list for a 
colonoscopy. Samples were taken from the caecum, transverse and descending colon 
and rectum and found that the prebiotic was able to increase the amount of 
Bifidobacteria found within the proximal (5.3 to 6.3 log10 CFU/mL) and distal (5.2 to 
6.4 log10 CFU/mL) colon. They also observed an increase in Lactobacilli in the proximal 
(3.0 to 3.7 log10 CFU/mL) and distal (3.1 to 3.6 log10 CFU/mL) colon. Kaplan and 
Hutkins (2000) added 2% (w/v) FOS to De man, Rogosa, Sharpe (MRS) agar and tested 
28 strains of lactic acid bacteria and Bifidobacteria. They reported that 12 out of the 16 
Lactobacillus spp. and 7 out of the 8 Bifidobacterium spp. were able to grow on plates 







Galactooligosaccharides (GOS) are produced from lactose by enzymatic 
synthesis (transgalactosylation) using β-galactosidases. The product consist of 
oligosaccharides from tri- to pentasaccharides with β-(1→6), β-(1→3), and β-(1→4) 
linkages, with DP ranging between 2 and 8 (Figure 2.2). The enzyme used during 
manufacture affects the composition, subsequently determining the  DP as well as 
linkages found within the end product (Mussatto and Mancilha, 2007; Rastall, 2007; 
Roberfroid, 2007). Galactooligosaccharides have been shown to selectively enhance the 
growth of Bifidobacteria while decreasing pathogenic bacteria (Fooks et al., 1999; 
Rastall, 2007; Roberfroid, 2007). Depeint et al. (2008) investigated the ability of a novel 
GOS produced via β-galactosidase originating from a probiotic Bifidobacterium bifidum 
strain against a GOS produced through an industrial β-galactosidase and a placebo on 
healthy human volunteers. During the first stage, 59 healthy humans (average age 34.4) 
received 7 g/d commercially available GOS for 7 d, followed by a 7 d washout period 
after which 30 volunteers received a sequence of treatments of novel GOS at either 0, 
3.6, or 7 g/d for 7 d. The stool was evaluated and they reported that the novel GOS 
significantly increased the Bifidobacteria population ratio compared to the placebo. 
Volunteers receiving 7 g/d of the novel GOS had a significant (p<0.05) increase in the 
Bifidobacteria population ratio compared to the commercial GOS. The authors also 
reported a relation between Bifidobacteria proportion and dose of novel GOS received. 
They conclude that GOS was able to increase the amount of Bifidobacteria within the 




Lactulose is produced by alkaline isomerisation of lactose to produce 4-O-β-
glactopyranosyl-D-fructose (Figure 2.3) (Mussatto and Mancilha, 2007). Although 
lactulose has been recognized as a prebiotic for many years, it has also been shown to be 
















Figure 2.2 Chemical structure of galactooligosaccharides, n = the number of 






















Bifidobacteria population while decreasing less desirable bacterial groups (Casci et al., 
2007; Rastall, 2007).A human study by Ballongue (1997) investigated the effect of 
lactulose on 36 human volunteers in a randomised, double-blind study. When volunteers 
were fed lactulose (10 g twice a day) for 4 wks an increase in the number of faecal 
Bifidobacterium spp. and Lactobacilli spp. along with a decrease in the number of 
Bacteroides spp, Clostridium spp., and coliforms were reported.  
 
2.2.2 Health benefits associated with prebiotics 
There are many health benefits associated with consuming prebiotics, including: 
significantly modifying the colonic microbial ecosystem, improved mineral/ion 
absorption, and regulation of lipid levels (Delzenne and Roberfroid, 1994; Mussatto and 
Mancilha, 2007; Rastall, 2007; Sarkar, 2007).  
(a) Improved microbial balance: Clinical trials have shown that the addition of 
prebiotics to the diet results in an increase in Bifidobacteria content within the feces 
and a decrease in detrimental bacteria (Gibson et al., 1995a; Buddington et al., 1996; 
Bouhnik et al., 1999). Gibson and co-workers (1995a) measured the affect of FOS 
and inulin diet addition on colonic bacteria of eight human volunteers over a 45 d 
period. Individuals were fed controlled diets of 15 g of sucrose for 15 d, then 15 g of 
FOS (Raftilose, DP = 2-8) or inulin (Raftiline, DP of 10) for 15 d, followed by a 
second control period of 15 d supplemented with 15 g sucrose. The bowel habit, 
transit time, stool composition, and breath H2 and CH4 were all measured. The 
authors reported there was an increase in stool frequency by 14% and 34% when 
FOS and inulin were ingested, respectively. The Bifidobacteria content from 
increased 8.8 to 9.5 log10 g/stool and 9.2 to 10.1 log10 g/stool when FOS and inulin 
were added to the diets, respectively, whereas pathogenic bacteria, Bacteriodes, 
Clostridia, and Fusobacteria decreased. They concluded that the consumption of 
dietary FOS and inulin may improve intestinal health.    
(b) Increased absorption of minerals/ions: The consumption of prebiotics has also 
been associated with the increased absorption of minerals/ions (Gibson and 





rats fed a diet supplemented with fermentable FOS with high and low degrees of 
polymerization. The rats were fed 10% Raftilose (DP = 4.8) or Raftiline (DP = 10) 
and the apparent retention of gross energy, nitrogen, and calcium, magnesium, iron, 
zinc, and copper contents was measured. The authors reported that there was a 
decrease in the fecal excretion of minerals suggesting the improved absorption of 
calcium, magnesium, iron, and zinc (Delzenne et al., 1995). Similar results were 
observed in a human study with adolescent girls, where a diet supplemented with 
short chain FOS (DP = 2-4) for 36 d increased magnesium absorption by 18% (van 
den Heuvel et al., 2009). 
(c) Healthier lipid profiles: Prebiotics have also been shown to reduce plasma 
triglycerides, phospholipids, and cholesterol (Fiordaliso et al., 1995). Rats fed daily 
10% FOS in their diet demonstrated a 25% decrease in plasma triglycerides, a 15% 
decrease in phospholipids, and a 15% reduction in cholesterol. High levels of plasma 
triglycerides and cholesterol are well known to increase one’s risk of coronary heart 
disease. The ability of prebiotics to reduce the aforementioned can reduce the risk of 
developing coronary heart disease. 
Many studies support the health benefits of consuming prebiotics. However, most of 
these studies have focused on the ingestion of FOS and inulin as the prebiotics source, 
with few studies focusing on other prebiotics. More studies are required to clearly 
establish these health claims and determine the mechanisms and roles prebiotics have in 
a human diet. There are few problems found to be associated with the use of prebiotics, 
however a major issue with overconsumption of prebiotics can cause diarrhea or 
flatulence (Crittenden and Playne, 1996). 
 
2.3 Synbiots 
Synbiots are defined by Gibson and Roberfroid (1995b) as “a mixture of 
probiotics and prebiotics that beneficially affects the host by improving the survival and 
implantation of live microbial dietary supplements in the gastrointestinal tract, by 
selectively stimulating the growth and/or by activating the metabolism of one or a 





Synbiots are a combination of a prebiotic and probiotic bacteria in which  the live 
bacteria is used in conjunction with a specific substrate for growth (Collins and Gibson, 
1999; Fooks et al., 1999). Some synbiots suitable for human consumption include, FOS 
and Bifidobacterium longum, B. infantis, and Lactobacillus acidophilus; GOS and B. 
lactis B. breve, and L. casei; and lactulose and B. lactis (Rastall and Maitin, 2002; 
Hawrelak, 2007; Rouzaud, 2007). The combination of both prebiotics and probiotics 
could improve survival of the probiotic due to provision of a readily available and 
specific substrate. The prebiotics provides a carbon source during colonization of the 
probiotic and may also be used by other beneficial microorganisms already present 
within the colon (Collins and Gibson, 1999; Fooks et al., 1999; Rouzaud, 2007). 
Administration of probiotics and prebiotics can be done as separate entities or in 
combination (synbiot). The combined use of probiotics and prebiotics could produce 
many nutritional benefits including: improved survival of live bacteria in food products; 
increased number of ingested bacteria reaching the colon in a viable form; and 
stimulation of growth and implantation of both exogenous and endogenous bacteria 
within the colon (Gibson and Roberfroid, 1995b).  
 
2.4 Probiotic and prebiotic utilization 
 The ability of bacteria within the colon to ferment prebiotic oligosaccharides is 
influenced by the chemical structure, degree of polymerization, and conformation (linear 
or branched), as well as water solubility of the prebiotic. In general, fructans which are 
considered to be the most susceptible to fermentation have short chain lengths, 
unbranched structure and are soluble in water (Biedrzycka and Bielecka, 2004). 
Fructans have also been found to show differences in their ability to stimulate growth of 
Bifidobacteria and Lactobacillus strains based on DP values (Perrin et al., 2002; 
Bañuelos et al., 2008). According to Coudray et al. (2003), a DP value of 10 represents a 
critical physiochemical threshold, where levels < DP 10 are fermented more readily by 
bacteria than larger chains (> DP 10). The majority of Bifidobacteria (except for B. 
bifidum) and some Lactobacillus spp. are able to ferment FOS due to the production of 
relatively high amounts of β-fructosidase, which selectively cleaves β-(2→1) linkages 





to more efficiently metabolize FOS with a DP ranging between 2 and 3 than FOS with 
DP >4. The authors studied the ability for two Lactobacillus strains; L. fermentum 
CECT5716 and L. gasseri CECT5714 to ferment Actilight®, FOS-AES, Raftilose® P95, 
and Raftline HP®. Actilight® is synthesized by enzymatic transglycosylation and has a 
DP of 2-4. FOS-AES is syrup containing a mixture of FOS and is produced by 
enzymatic synthesis using a fungal fructosyltransferase. Raftilose® P95 is produced via 
enzymatic hydrolysis of chicory inulin and has a DP of 2-8 (DPav = 4). Raftline HP® is 
chicory inulin with DPav = 23. Banuelos et al. (2008) reported that the Lactobacillus spp. 
had very low growth on Raftilose® P95 and Raftline HP® containing media which were 
both produced by enzymatic hydrolysis. They also reported that 1-kestose (GF2) was the 
only prebiotic which was significantly metabolized by Lactobacillus spp. Therefore, 
fructans produced by enzymatic synthesis with a DP of 2 to 3 were more efficiently 
metabolized by Lactobacillus. The preference for shorter chain oligosaccharides can 
also be seen in Bifidobacterium spp. Biedrzycka and Bielecka (2004) reported results 
which showed that the majority of Bifidobacteria strains tested preferentially utilized 
short chain FOS (DP = 2-4), oligofructose (DP = 2-8), and low polymerized inulin (DP 
≤ 9) compared to highly polymerized inulin and highly purified inulin.  
 
2.5 Encapsulation technology 
 Encapsulation refers to the entrapment of solids, liquids, or gaseous materials 
within small capsules/particles that can release their contents at controlled rates under 
the influences of specific environmental conditions (e.g., pH, temperature, presence of 
salts, enzymatic degradation, etc.) (Dziezak, 1988; Desai and Park, 2005; Anal and 
Singh, 2007). Capsules allow for the entrapped ingredient to be separated and protected 
from its environment until release of the functional ingredient is desired (Ross et al., 
2005). Capsules can vary in size, ranging from microns to millimetres (Dziezak, 1988; 
Desai and Park, 2005) and are grouped into three broad categories based on size: 
macrocapsules (>5000 µm), microcapsules (5000 µm to 0.2 µm), and nanocapsules 
(<0.2 µm) (King, 1995). In general, the entrapped ingredient is referred to as the core 
material or active ingredient, whereas the outer material is referred to as the wall 





ingredients are hydrocolloids (Roberfroid and Slavin, 2000; Anal and Singh, 2007). 
Common hydrocolloid wall materials used within the food industry include AL, agar, 
carrageenan, cellulose, gelatin, gum Arabic, gellan gum, low -methoxy pectin, 
maltodextrins, starch, and whey protein (King, 1995). In the case of probiotics, capsule 
materials act to protect the viability of the microbe during food manufacture, storage and 
transit through the gastrointestinal tract, with the objective of delivering high numbers 
(107 CFU/g of food) to the colon. Literature relating to probiotic encapsulation is 
dominated by either extrusion (Krasaekoopt et al., 2003; Chandramouli et al., 2004; 
Chen et al., 2005; Iyer and Kailasapathy, 2005; Muthukumarasamy et al., 2006) or 
emulsion-based (Sultana et al., 2000; Hansen et al., 2002; Krasaekoopt et al., 2003; 
Crittenden et al., 2006; Muthukumarasamy et al., 2006) techniques.  
 
2.5.1 Extrusion-based probiotic encapsulation 
 Extrusion is one of the most commonly used techniques for entrapping 
probiotics due to its ease, simplicity, and low cost. The gentle formulation conditions 
during extrusion ensure a high retention of cell viability and produces uniform capsules 
(King, 1995). The technique involves mixing a hydrocolloid solution with a live 
probiotic culture, then extruding the mixture through a syringe needle to form droplets 
which then free fall into a cross-linking or hardening solution (Figure 2.4) (King, 1995; 
Krasaekoopt et al., 2003). Wall material, hydrocolloid concentration, and size of the 
capsule all influence survival of the entrapped ingredient. For instance, 
Muthukumarasamy et al. (2006) looked at various wall materials for the encapsulation 
of probiotic Lactobacillus reuteri and measured the survival of the probiotic during 
gastric challenges (simulated gastric juice (SGJ), pH 1.5 for 2 h). Alginate (AL) (3.0% 
w/v), AL (2.0%, w/v) + starch (2.0%, w/v), κ-carrageenan (1.75%, w/v) + locust bean 
gum (0.75%, w/v), or xanthan (1.0%, w/v) + gellan (0.5%, w/v) were used as the wall 
material. They reported that AL and AL + starch provided the best protection against 
SGJ. The concentration of wall material and capsule size can also have an effect on the 
ability to protect the core ingredients. Lee and Heo (2000) investigated the influence AL 
concentration (2.0, 4.0, and 6.0% AL) and capsule size (1.03, 1.75, and 2.62 mm) had 














Figure 2.4 Process flow diagram for the encapsulation of probiotic bacteria using 






probiotic with increased AL concentration. Larger capsules were able to protect the 
probiotic better than small capsules produced. Muthukumarasamy et al. (2006) reported 
large capsules made by the extrusion technique (2-4 mm) provided better protection 
compared to smaller capsules produced via the emulsion technique (20-1000 µm).   
The size of the capsule produced during extrusion depends on the diameter of the 
syringe needle, the hydrocolloid concentration, viscosity of the solution, and the 
distance between the syringe and cross-linking solution. The major factor influencing 
the capsule size is the diameter of the syringe needle used during extrusion. 
Muthukumarasamy et al. (2006) formed capsules using a 21gauge (G) needle with 
various wall materials, AL (2-3 mm), AL-starch (2-3 mm), κ-carrageenan-locust bean 
gum (3-4 mm), xanthan-gellan (2-3 mm). Lee and Heo (2000) used a 20 G needle to 
obtain AL capsules between the size of 1-2.6 mm. Chen et al. (2005) encapsulated 
probiotics in AL capsules with FOS and/or isomaltooliosaccharides and casein using a 
31 G needle and produced a capsule size of ~0.5 mm. The shape of the capsule can also 
be affected by the biopolymers used and biopolymer concentration. Sandoval-Castilla et 
al. (2010) investigated  various biopolymer compositions and their effect on diameter 
and sphericity of the formed capsules using AL and amidated low-methoxyl pectin 
blends. They reported that capsule mean sizes ranged from 0.71-0.93 mm using a 30.5 G 
needle. Additionally, when pectin was added it significantly increased the size of the 
capsules compared to AL alone. The sphericity of the capsule also was significantly 
influenced by the presence of pectin. When AL was present the sphericity of the 
capsules was higher. An important challenge for probiotic encapsulation is the ability to 
achieve high rate of survival during storage and gastrointestinal transit. Large capsule 
can achieve high cell loads within the capsule and provide increased survival, however 
when large capsules are produced the textural and sensorial properties of food products 
in which they are added can be negatively affected (Muthukumarasamy et al., 2006; 
Sandoval-Castilla et al., 2010). 
Prebiotics can be added into the hydrocolloid solution along with the probiotics 
allowing them to be entrapped together, or prebiotics can be applied as an additional 
coating post capsule formation. The addition of prebiotics can enhance the survival of 





affect of adding inulin (Raftiline), a FOS (Raftilose), and high amylose corn starch (Hi-
maize) to the probiotic capsule and reported that bacteria co-encapsulated with prebiotic 
had increased survival under in vitro acid conditions compared to non-encapsulated and 
encapsulated bacteria with no prebiotic added. 
 
2.5.2 Emulsion-based probiotic encapsulation 
 Emulsion-based techniques are another common method employed for the 
encapsulation of probiotic bacteria. This technique consists of a mixture of immiscible 
liquids (typically oil and water) with the aqueous hydrocolloid phase and cell suspension 
representing the dispersed phase and the oil representing the continuous phase 
(Krasaekoopt et al., 2003; McClements et al., 2009). Typically, the continuous phase 
consists of vegetable oil such as soybean, sunflower, canola or corn. Emulsions are 
prepared by the addition of a small volume of the discontinuous (aqueous) phase to a 
larger volume of the continuous phase (oil), followed by homogenization to form a 
water-in-oil emulsion (Figure 2.5). Typically emulsifiers are also added (such as Tween 
80) to the continuous phase to ensure homogeneity (Rokka and Rantamaki, 2010). Once 
the emulsion is formed a cross-linking agent is added to precipitate the water soluble 
hydrocolloids to form gel particles (microcapsules) within the oil (Krasaekoopt et al., 
2003; Rokka and Rantamaki, 2010). This technique can produce capsules ranging in size 
between 25 µm - 2 mm. The size of the capsule is controlled by the speed of agitation 
and concentration of hydrocolloids. This technique can be beneficial due to its ability to 
produce smaller capsules than can be achieved via extrusion. It is generally accepted 
that capsules > 100 µm has a negative effect on textural and sensorial properties of the 
food products (Hansen et al., 2002; Sandoval-Castilla et al., 2010). However, small 
capsules have limited ability to protect the probiotic bacteria through gastrointestinal 
transit. Emulsion technology also produces a wide size distribution. Hansen et al. (2002) 
tested the ability of AL capsules prepared via emulsion technique to protect four 
Bifidobacterium spp. (B. adolescentis 15703T,  B. breve 15700T, B. lactis Bb-12, and B. 
longum Bb-46) against SGJ (pH 2.0, 3.0 and 6.0). The capsules produced were 20 µm 















Figure 2.5 Process flow diagram for the encapsulation of probiotic bacteria using 






significantly improve survival within SGJ over the 2 h incubation. Sultana et al. (2000) 
investigated L. acidophilus, L. casei, and B. infantis probiotics in 2% AL emulsion-
based capsules containing 2% Hi-maize resistant starch. With a capsule size ranging 
from 0.5 to 1 mm there was no significant increase in survival during SGJ challenge 
experiments. 
Research in the current study will focus only on the use of extrusion processing 
for the encapsulation of prebiotic oligosaccharides and probiotics, in order to test the 
effect of wall material properties without having a confounding size effect of variable 
capsule distribution 
2.6 Biopolymer mixtures as a wall material 
 Typically, probiotic encapsulation matrices are comprised of one or more 
hydrocolloid material (Chandramouli et al., 2004; Krasaekoopt et al., 2004; Reid et al., 
2005), or may have additional coating layers of another material (Krasaekoopt et al., 
2004; Iyer and Kailasapathy, 2005; Gbassi et al., 2009). The latter provides additional 
protection to entrapped viable microorganisms from processing and storage conditions, 
and during transit through the gastrointestinal tract. The present research investigates the 
potential of a wall matrix comprised of a protein-polysaccharide mixture (i.e., pea 
protein isolate and AL polysaccharides) to offer protection to the entrapped bacteria.  In  
mixed systems, biopolymers depending on their electric charge will either undergo: a) 
segregative phase separation, in which the biopolymers do not interact due to 
electrostatic repulsive forces between reactive groups of similar charges; or b) 
associative phase separation, in which biopolymers come together due to electrostatic 
attractive forces between reactive groups of opposing charges (Dziezak, 1988; de Kruif 
et al., 2004; Barbosa-Canocas et al., 2005). Depending on the biopolymer conditions 
(e.g., concentration, ratio, biopolymer-type, reactive group present and molecular 
weight), solvent (e.g., pH, temperature and salts) and processing (e.g., degree of shear) 
conditions, the phase behaviour and structure of the resulting matrix can be tailored 
(Weinbreck et al., 2003a). Although food products containing probiotics have primarily 
targeted dairy products (e.g., yogurts); transitioning to an entirely plant-based matrix 
versus animal derived biopolymers may open up new markets and products where the 







Alginate is the most commonly used wall material for extrusion-based probiotic 
encapsulation (Krasaekoopt et al., 2003). Alginate is the salt of alginic acid which 
naturally occurs in marine brown algae (Phaeophyceae) as the main structural 
component. Alginate is also in the extracellular mucilages secreted by some bacterial 
species (Draget et al., 2006; Harnsilawat et al., 2006). Alginate is a linear 
polysaccharide of (1→4)-linked β-D- mannuronic acid (M) and (1→4) -linked α-L-
guluronic acid (G) residues which are found in homo- or hetro-polymeric block 
sequences (Figure 2.6). Alginate polysaccharides are anionic in nature, remaining 
negatively charged over a wide pH range until their carboxyl reactive sites become fully 
protonated at pH 1.88 (Liu et al., 2009). The α-L-guluronic acid residues are highly 
sensitive to calcium salts, forming ‘egg-box’-like junction zones which then lead to the 
formation of polysaccharide-based networks (Sabra and Deckwer, 2005). Alginates rich 
in G units form strong, dense and brittle gels, whereas ALs which have a high 
proportion of M units form soft, elastic gels.  
Using alginates as an encapsulating agent has given mixed success in terms of 
offering protection to probiotic bacteria. Chandramouli et al. (2004) encapsulated L. 
acidophilus by extrusion using different AL concentrations (0.75-2.00%, w/v), CaCl2 
concentrations (0.1, 0.2, and 1.0 M) and bead size (200, 450, and 1000 µm). The authors 
found cell viability in SGJ increased with increasing capsule size (200-1000 µm) and 
AL concentration (0.75–2.0%, w/v), whereas CaCl2 concentration showed no effect on 
viability of encapsulated cells. At higher capsule sizes (1000 µm vs. 450 µm) and higher 
AL concentrations (2.00% vs. 1.80% w/v) no significant increases in viability were 
observed, therefore the optimal conditions for entrapment of L. acidophilus (9 log 
CFU/mL) was determined to be with 1.80% (w/v) AL with a capsule size of 450 µm. 
Entrapment led to a 3 log reduction in bacterial counts, whereas non-encapsulated cells 
experienced a 5 log reduction when exposed to simulated gastric conditions at pH 2.0 
for 3 h. Muthukumarasamy et al. (2006) investigated different wall materials for 
entrapping L. reuteri in order to protect cell viability during gastric challenges. These 














Figure 2.6 Schematic of homo- or hetro-polymeric sequences of (1→4)-linked                        
β-D-mannuronic acid and (1→4)-linked α-L-guluronic acid residues of 





with gellan. The capsules were prepared by either extrusion or emulsion techniques. 
They reported the survival of L. reuteri was significantly increased when encapsulated 
compared to non-encapsulated cells and that encapsulation by extrusion with AL or 
AL/starch provided the greatest protection against gastric juice, with less than 0.5 log 
reduction from initial cell counts. However, other studies have reported AL capsules do 
not significantly improve survival of entrapped probiotic bacteria. Hansen et al. (2002) 
reported AL capsules produced via an emulsion technique did not significantly improve 
the survival of B. adolescentis, B. breve, B. lactis, or B. longum compared to the non-
encapsulated cells when subjected to SGJ (pH 2.0 and 3.0) for 2 h. Krasaekoopt et al. 
(2004) investigated the survival of B. bifidum, L. acidophilus, and L. casei in SGJ (pH 
1.55) and sequentially placed into intestinal juice with and without bile salt. They 
reported no survival of B. bifidum either as encapsulated or as free cells in SGJ. They 
found that the survival rate of L. acidophilus in AL beads improved compared to non-
encapsulated bacteria after sequential incubation in SGJ and intestinal juices with and 
without bile salt. However, the highest survival rate was observed when AL beads were 
coated with chitosan. For L. casei they found AL beads only slightly improved survival 
compared to non-encapsulated cells (1 log CFU/mL difference), however chitosan 
coated AL beads significantly improved survival. Krasaekoopt et al. (2004) does not 
report an explanation for the improved survival of chitosan coated beads compared to 
AL alone and other coating materials used. However, it is assumed chitosan improves 
the physical barrier separating the probiotic bacteria from the low acid of SGJ. This 
could be due to reduced pore size within the capsule; however no information was 
provided on the capsule’s structure in this paper.   
 
2.6.2 Pea protein isolates 
Field peas (Pisum sativum) are comprised of ~20-30% protein, primarily 
consisting of salt-soluble globulins and water-soluble albumins (Schroeder, 1982). 
There are two major globulin proteins, legumin and vicilin which represent 65-80% of 
the extractable pea protein. Legumin is a hexameric 11S protein with a molecular weight 
between 350-400 kDa, whereas vicilin is a trimeric 7S protein with a molecular mass of 





is ~4.5, however depending on the extraction process pIs can range between 4.0 and 6.0 
(Koyoro and Powers, 1987). Encapsulation using pea protein materials has been limited, 
with some research in the entrapment of oil (Ducel et al., 2004), ascorbic acid (Pierucci 
et al., 2006; Pereira et al., 2009), α-tocopherol (Pierucci et al., 2007), and β-carotene (De 
Graaf et al., 2001). 
 
2.6.3 Pea protein isolate–alginate mixtures 
The use of protein as an encapsulating agent has been previously reported to 
increase the survival of probiotics against SGJ (Reid et al., 2005; Kotikalapudi et al., 
2010; Wood, 2010). Reid et al. (2005) encapsulated L. rhamnosus via extrusion using a 
70:30 mixture of 12% whey protein isolate (WPI)-bacteria. The authors subjected the 
capsules to a dynamic gastrointestinal model which varied in pH from 4.4 to 2.0 over 90 
min and found that encapsulated cells had a 2.4 log CFU/mL reduction where as free 
cells experienced a 4 log CFU/mL reduction in viable bacteria. Kotikalapudi et al. 
(2010) also encapsulated L. acidophilus within a PPI-AL. Kotikalapudi et al. (2010) 
investigated a panel of commercially available probiotics strains (Lactobacillus 
acidophilus, Bifidobacterium longum subsp. infantis, B. catenulatum, and B. 
adolescentis) for their acid resistance, bile resistance, adherence to Caco-2 cells, and 
carbon source utilization. The authors encapsulated L. acidophilus within a 4.0% PPI-
0.5% AL capsule and subjected it to simulated gastric juice. They reported non-
encapsulated L. acidophilus demonstrated the most resistance to SGJ (pH 2.0) compared 
to the other non-encapsulated probiotics strains, however it could not survive longer that 
30 min. They found all probiotics were able to survive for 5 h in MRS media 
supplemented with 0.3% bile. The authors performed an in vitro adherence test of 
probiotics bacteria to Caco-2 cells as an indicator of which probiotic strain would have 
the best adherence to the intestinal wall and found that L. acidophilus adhered to the 
Caco-2 cells best. The ability to utilize carbon sources was also investigated and they 
found that all strains had highest growth on D-xylose; however, no test was performed 
on prebiotic FOS. Due to their findings, Kotikalapudi et al. encapsulated L. acidophilus 
within a 4.0% PPI-05% AL capsule and subjected it to SGJ (pH 2.0) for 2 h and 





with only 1log reduction in cell viability compared to unprotected cells which 
experienced > 6 log loss.  
Wood (2010) investigated the growth of the probiotic, Bifidobacterium 
adolescentis, on various prebiotic sources (i.e., short chain FOS, inulin, FOS/inulin 
mixtures, glucose and a glucose-free maltooligosaccharide). B. adolescentis was better 
able to utilize short chain FOS as a carbon source. The probiotic was also investigated 
using various wall materials (i.e., AL, PPI-AL and WPI-AL mixtures) with and without 
short chain FOS by extrusion, followed by challenge studies within SGJ at pH 2.0 for 2 
h. Capsules containing both WPI and PPI protein were able to protect B. adolescentis, 
whereas those with AL only offered minimum protection. The addition of FOS 
improved the survival of B. adolescentis within the PPI-AL capsules relative to without. 
Wood hypothesized that the protein-based capsules had greater survival than AL alone 
due to a less porous capsule wall as imaged by cryo-scanning electron microscopy, and 
that this would likely slow the diffusion of SGJ into the capsule.  
Within the current study probiotic capsules will be produced using PPI-AL 
mixtures to build upon the initial work by Wood (2010) using controlled phase 
separation as a means to alter the wall design and improve probiotic survival under SGJ 
conditions and to enhance release within simulated intestinal fluid (SIF). AL and PPI 
interactions are investigated as a function of pH and biopolymer mixing ratio to 
determine their phase behaviour based on associative and segregative phase separation. 
The capsule wall material and processing conditions will be altered to improve the 
capsule design based on the total biopolymer concentration, addition of a prebiotic 
source (FOS) and altering needle gauge during extrusion processing. Changes to the 
capsule wall material and processing conditions will be tested to determine the impact 
on the physical properties of the capsule and ability to protect the probiotic in SGJ. In 
addition to work performed by Wood et al. (2010), pea is attractive as a plant protein 
source since it is commercially available and important to Saskatchewan economy.  
2.7 Phase separation within PPI-AL mixtures 
Associative phase separation (also known as complex coacervation) occurs when 
two biopolymers of opposing net charges experience electrostatic attraction, whereas 





experience electrostatic repulsive forces (de Kruif et al., 2004). Depending on the 
biopolymer (e.g., concentration, ratio, biopolymer-type, reactive site present, linear 
charge density of reactive sites), solvent (e.g., pH, temperature and salt) and processing 
(e.g., degree and duration of shear) conditions, phase separation can be controlled. 
When using biopolymers as coating agents, phase separation can be used to tailor the 
wall properties and ultimately its protective potential for entrapped probiotics.  Pea 
protein isolate assumes an overall positive charge at pHs below the pI (pH ~4.5), 
creating an environment where associative phase separation could ensue at pH<pI and 
segregative phase behaviour at pH>pI. A schematic representation describing various 
phase separating scenarios is given in Figure 2.7 (Goh et al., 2009). Typically in dilute 
solutions, biopolymers remain suspended and co-soluble, with little interactions 
regardless of charge (Figure 2.7a). As the total biopolymer concentration rises, 
biopolymers of similar net charge repel one another, separating into both a protein- and 
polysaccharide-rich phase (Figure 2.7b). If the biopolymers are of opposing charges, 
phase separation leads to the formation of both a solvent-rich and biopolymer-rich 
(protein + polysaccharide) phase. The latter is thought to occur in two structure forming 
events following nucleation and growth-type kinetics (Weinbreck et al., 2003a; Girard et 
al., 2004): first, with the formation of soluble complexes (Figure 2.7c); and then with the 
formation of insoluble complexes (Figure 2.7d) (Ye, 2008; Goh et al., 2009). Depending 
on the strength and degree of electrostatic attractive forces involved during 
coacervation, a coacervate structure or precipitate may form. It should be noted that 
coacervates are not the same as precipitates. Coacervate structure tends to be less 
compact, entraps more solvent then precipitates, is completely reversible and remains 
suspended within the biopolymer–rich phase. In contrast, due to their stronger 
electrostatic interactions precipitates are more compact, entrap less solvent, are less 


















Figure 2.7 Schematic diagram representing various phase separation behaviours 






2.7.1 Factors affecting phase separation 
 Phase separation in biopolymer mixtures is primarily influenced by factors that 
disrupt the electrostatic attractive or repulsive forces occurring between the protein and 
polysaccharides, such as pH, salt, and biopolymer mixing ratio. The latter refers to the  
number of reactive sites (positive and negative) available to interact with the 
neighbouring biopolymer. These factors are discussed below: 
pH: Solvent pH plays a significant role in controlling the number of ionizable 
reactive sites along the biopolymer’s backbone: this is particularly important in the 
case of proteins where the molecule can assume a positive charge at pH < pI and a 
negative charge at pH > pI. Hence, in the presence of an anionic polysaccharide such 
as AL associative phase separation with the positively charged protein can occur at 
pH < pI to form a soluble/insoluble complex. In the case of a protein and 
polysaccharide mixture complex coacervation occurs over a narrow pH range and 
generally occurs between the pKa of the polysaccharide and the pI of the protein 
(Tolstoguzov, 1997; Ducel et al., 2004). During complex formation there are two 
main pH-induced structure forming events associated with the formation of soluble 
and insoluble complexes. The former event (denoted as pHc) occurs at pH 
corresponding to the first experimentally detectable increase in turbidity during a pH 
titration and is the initial site of soluble complex formation. This is followed by a 
second structure forming event at pHφ1, associated with the formation of insoluble 
complexes and a large rise in turbidity. Optimal complex formation is considered to 
occur at pH where both biopolymers reach their electrical equivalence, donated 
pHopt, which is followed by dissolution of the complexes at lower pH (pHφ2), due to 
protonation of reactive groups on the polysaccharide backbone (Liu et al., 2009). For 
instance, Liu et al. (2009) investigated the effect of pH on the complex formation 
between PPI and gum Arabic (biopolymer mixing ratio, 1:1 PPI-gum Arabic; and 
polymer concentration, 0.05% (w/w)) and reported that structure forming transitions 
pHc, pHφ1, pHopt, and pHφ2 occurred at pH 4.2, 3.7, 3.5, and 2.5, respectively. Below 
a pH of 2.5 the carboxyl groups on gum Arabic become protonated (pKa = 2.2). In 





resulting in electrostatic repulsion to occur. This inhibited complex coacervation. 
However, in some cases, such as in the presence of a strongly charged 
polysaccharide (e.g. carrageenan), associative phase separation may occur when the 
overall net charge on both biopolymers is negative. This phenomenon has been 
reported for WPI and carrageenan (Weinbreck et al., 2004a), pectin and WPI 
(Zaleska et al., 2000), and bovine serum albumin and 
poly(dimethyldiallylammonium chloride (Wen and Dubin, 1997), and is thought to 
be attributed to the interactions with localized positively charged patches on the 
protein’s surface (Schmitt et al., 1998; Doublier et al., 2000; de Kruif et al., 2004; 
Weinbreck et al., 2004a).  
Salt: As previously stated, the charge on the biopolymers is extremely important and 
determines the intensity with which the biopolymers interact or repel one another. 
The addition of salt is another major factor which influences the formation of 
complexes and affects the screening of charges present on the biopolymers (Schmitt 
et al., 1999). In general, the addition of salt at low concentrations helps to promote 
electrostatic interactions between biopolymers, as ions associate with protein 
structure alter its conformation to expose additional charged groups. However, at 
high salt concentrations, ions screen charges along the biopolymers, resulting in 
reduced electrostatic attractive forces which suppresses complex coacervation 
(Weinbreck et al., 2003a). Depending on the biopolymers used, the amount of salt 
that must be added to promote complex coacervation varies. Weinbreck et al. 
(2003a) reported that a concentration of <50 mM NaCl improved complex 
coacervation between WPI and gum Arabic, whereas at levels >50 mM NaCl 
complexation was inhibited due to this screening effect. Liu et al. (2010a) reported 
that 100 mM NaCl suppressed complex formation between pea protein and gum 
Arabic mixtures. 
Biopolymer mixing ratio: Biopolymer mixing ratios also has a significant effect on 
phase separation. Due to the fixed charge density of proteins and polysaccharides at 
a given pH, by adjusting the biopolymer mixing ratio, the total charges available for 





investigated the effect of biopolymer mixing ratios on complex coacervation 
between WPI and the exocellular polysaccharide B40 (ESP B40). These researchers 
found that the formation of soluble complexes (pHc) was independent of mixing 
ratios between 1:1 and 25:1 (WPI-ESP B40). This stability was thought due to the 
interaction of a simple polysaccharide chain with given amount to protein. Mattisson 
et al. (1995) and Weinbreck et al. (2004a) reported a similar pHc independence of 
mixing ratios for bovine serum albumin-poly (dimethyl diallyl ammonium chloride) 
(PDMDAAC) and WPI-carrageenan, respectively. Alternatively, some researchers 
have found pHc to be dependent on mixing ratio, for instance in systems of gelatin–
agar (Singh et al., 2007) and PPI–gum Arabic (Liu et al., 2009). Liu et al. (2009) 
reported pHc to be dependent on biopolymer mixing ratios of <4:1 after which pHc 
became constant at higher biopolymer mixing ratios, suggesting that this was due to 
complexation of gum Arabic with protein-protein aggregates rather than single 
molecules as reported by Weinbreck et al. (2003b). Weinbreck et al. (2003b) also 
reported that for WPI-ESP B40 mixtures, the formation of insoluble complexes 
(pHφ1) was found to be ratio dependent where pHφ1 shifted to higher pHs as ratios 
increased from 1:1 to 9:1 WPI-ESP B40, before becoming constant at ratios >9:1. At 
the plateau, charged groups on the protein were presumed saturated by the 





3. Materials and Methods 
3.1 Materials 
 For this research, pea flour (PF) (Fiesta Flour, lot F147X, 2008) was kindly 
donated by Parrheim Foods (Saskatoon, SK) and was used to produce a ‘native’ pea 
protein isolate (PPIn). A commercial pea protein isolate (PPIc) (ProPulse) was kindly 
donated by Nutri-Pea Ltd. (Portage la Prairie, MB).  
Orafti® P95 (FOS, DP 2-8 (6.8% D-glucose + D-fructose + D-sucrose) was 
kindly supplied by ORAFTI S.A. (Oreye, Belgium).  
 The following materials and chemicals were purchased from Sigma-Aldrich 
(Oakville, ON): acetic acid, alginic acid sodium salt from brown algae (viscosity of 
2.0%, lot 065K0237), L-cysteine hydrochloride monohydrate, D-fructose, glucono-δ-
lactone (GDL), α-D-glucose, pancreatin (amylase, 108 USP units/mg; protease, 100 
USP units/mg; lipase and ribonuclease, unknown concentrations; batch 039K1579), 
phenol, and Tween 80.  
Hydrochloric acid (6 N) (HCl) was purchased from Ricca Chemical Company 
(Arlington, TX).  
Calcium chloride dehydrate (CaCl2), N-point indicator, petroleum ether, 
potassium chloride (KCl), sodium acetic acid (Na+CH3COO-), sodium chloride (NaCl), 
and sodium phosphate dibasic heptahydrate (Na2HPO4) were purchased from EMD 
Chemicals (Darmstadt, Germany).  
Sodium hydroxide solution (NaOH, 50% w/w) and sulfuric acid (H2SO4) were 
purchased from Fisher Scientific (Fair Lawn, NJ).  
Protein dye reagent (Coomassie brilliant blue G-250 dye) and bovine serum 
albumin (BSA) (2.0 µg/µL) were purchased from Bio-Rad laboratories, Inc. (Hercules, 
CA).  
Glycerol, dipotassium hydrogen phosphate (K2H2PO4), and sodium bicarbonate 
(NaHCO3) were purchased from BDH Inc. (Toronto, ON).   
Boric acid and Kjeldahl catalyst (Kjel-Pak Mixture #200) were purchased from 





 Bifidobacterium adolescentis ATCC 15703 was purchased from American Type 
Culture Collection (Manassas, VA).  
Reinforced clostridial media (RCM), and De Man, Rogosa, Sharpe (MRS) media 
were purchased from Oxoid Ltd. (Basingstoke, England).  
BactoTM Peptone, Difco oxgall dehydrated fresh bile, and granulated Difco agar 
were purchased from BD (Becton, Dickson and Company, Sparks, MD). 
The following anaerobic gases were purchased from Praxair (Saskatoon, SK): 
ultra high purity nitrogen and a mixed system containing 80% nitrogen, 10% hydrogen 
and 10% carbon dioxide. 
The water used in this research labelled as ddH2O was produced from a 
Millipore milli-Q™ water system (Millipore Corporation, Milford, MA) unless otherwise 
stated. 
 
3.2 Proximate analysis 
 Proximate analyses on all materials (PF, PPIn, PPIc, and AL) were performed 
according to the Association of Official Analytical Chemists (AOAC, 2003). Methods 
925.10, 923.03, 920.87 and 920.85 for moisture, ash, crude protein and lipid (% wet 
weight basis), respectively. Sample carbohydrate content was determined as percent 
differential from 100%.  All chemical analyses were performed in triplicate. Individual 
methods are summarized briefly below. 
 
3.2.1 Percent moisture 
 Percent moisture was determined gravimetrically using a forced air drying oven 
(Fisher Scientific, Ottawa, ON) and an analytical balance (Metler, Columbus, OH). 
Samples of ~1 g (± 0.0002 g) were weighed into pre-dried (~16 h at 102 ± 2°C) 
aluminum dishes (VWR International, Mississauga, ON). Samples were dried overnight 
(16 h) at 102°C, and then placed within a glass desiccator containing drierite granules 
(Fisher Scientific, Ottawa, ON) to cool for 30 min, prior to gravimetric analysis. Percent 














× 100%     (eq.  1)  
 
where, Wi was the initial weight of the sample plus aluminum dish before drying (g), Wf 
was the final weight of the sample plus dish (g) after drying, and Ws was the original 
sample weight (g). 
 
3.2.2 Percent ash 
 A muffle furnace (Fisher Scientific, Ottawa, ON) was used to determine the ash 
content of all samples. Crucibles were pre-ashed in a muffle furnace (~550°C) for 3 h 
and then cooled to room temperature (30 min) within a glass desiccator containing 
drierite. Samples were weighed ~1 g (± 0.0002 g) using an analytical balance and placed 
directly into the pre-weighed pre-dried crucibles. Samples were heated within the muffle 
furnace at ~550°C overnight (~16 h) and then placed in a desiccator to cool to room 
temperature (30 min) prior to gravimetric analysis. The percent ash content was 
determined using the follow equation: 
 




× 100%      (eq.  2) 
 
where, Wi was the initial weight of the sample plus the crucible before pyrolysis (g), Wf 
was the final weight of the sample plus the crucible (g) after pyrolysis, and Ws was the 
original sample weight (g). 
 
3.2.3 Percent lipid 
 A Goldfisch apparatus (Labconco, Kansas City, MO) was used to determine the 
sample lipid content. Lipid extraction beakers were dried for 16 h in a forced air drying 
oven at ~102°C, and then placed in a glass desiccator containing dierite to cool to room 
temperature and weighed using an analytical balance. The materials were weighed (~3 g 





20 mm x 80 mm cellulose extraction thimbles (Whatman International Ltd, Maidstone, 
England). Thimbles were placed in a metal holder and fitted into the Goldfisch 
apparatus. Approximately 50 mL of petroleum ether was added to the pre-weighed lipid 
extraction beakers (150 mL) and the extraction process was initiated (5-6 drops/sec). 
The extraction time employed was ~6 h. Petroleum ether was reclaimed from the 
samples and the beakers were allowed to cool to room temperature in a fume hood. The 
lipid extraction beakers were then placed in a forced air drying oven (102°C) overnight 
(~16 h). After cooling to room temperature (desiccator), sample lipid content was 
determined gravimetrically. The lipid content was determined using the following 
equation: 
 




× 100%      (eq.  3) 
 
where, Wi was the initial weight of the sample plus the lipid extraction flask prior to 
extraction (g), Wf was the final weight of the sample plus lipid extraction flask (g) after 
extraction, and Ws was the original sample weight (g). 
 
3.2.4 Percent protein 
 The protein content of samples was determined using the Kjeldahl digestion 
method for nitrogen determination.  In brief, 0.5000 ± 0.0002 g of sample was weighed 
on nitrogen-free weighing paper (9.0 cm; VWR 410), folded and placed within a glass 
digestion flask. Concentrated H2SO4 (20.0 mL) and a catalyst tablet (10.0 g K2SO4, 0.3 g 
CuSO4: Kjel-Pak Mixture #200, VWR International, Mississauga, ON) was added to the 
flask, which was then placed on a Büchi Digestion Unit (Model K-435; Büchi 
Analytical Inc.; Potfach, Switzerland) for ~3 h. Individual solutions were cooled to 
room temperature, followed by dilution with 80.0 mL of ddH2O. The resulting solutions 
were steam distillated (Buchi Distillation Unit Model B-324; Büchi Analytical Inc.; 
Potfach, Switzerland) with the automatic addition of 80.0 mL of 30% (w/v) NaOH and 
25.0 mL of 4% (w/v) boric acid. Approximately 100-150 mL of the distillate was 





(methanol/water/bromocresol green/methyl red). Samples were titrated with 0.2000 N ± 
0.0002 HCl until the solution colour turned light pink. The protein content of the sample 





molgHClNVbVsNitrogen  (eq.  4)  
 
where, Vs and Vb was the volume of HCl (mL) used to titrate the sample and the blank, 
respectively, and Ws was the weight of the sample (mg). Percent protein was determined 
by multiplying the % Nitrogen by 6.25 (conversion factor). 
 
3.3 Prebiotic characterization using high performance liquid chromatography 
Carbohydrate analysis of P95 was performed using high performance anion 
exchange chromatography coupled with pulsed amperometric detection (HPAEC-PAD) 
(Dionex Bio LC 4000, Dionex, Sunnyvale, CA). A CarboPac PA1 (4 x 250 mm) anion 
exchange column was used in series with a CarboPac Guard PA-1 (4 x 50 mm) column 
(both from Dionex) for carbohydrate separation. All samples were syringe filtered (13 
mm diameter, 0.2 µm pore size, Chromatographic Specialities Inc., Brockville, ON) 
prior to HPAEC-PAD analysis. The sample injection volume was 50 µL. 
Oligosaccharides were detected by PAD using the following potentials and durations: E1 
= 50 mV, T1 = 0.299s; E2 = 600 mV, T2 = 0.299s; E3 = -800 mV, T3 = 0.499s. Data 
analysis was afforded using WMSP Chromatography Manager Software (Nanning 
Weimalong Chromatograph Science Technology Co., China). The mobile phase 
consisted of three eluents: eluent A, 100 mM NaOH; eluent B, 100 mM NaOH and 250 
mM sodium acetate; and eluent C, 300 mM NaOH. The following gradient program was 
used to achieve carbohydrate separation: initial, 100% eluent A for 8 min, followed by a 
linear gradient to 100% eluent B at 60 min, followed by a rapid change to 100% eluent 
C at 61 min, which was held for 29 min. At 91 min a rapid change to 100% eluent A 
occurred and was held until 120 min. The flow rate was maintained at 1.0 mL/min and 






3.4 pH determination 
 Sample pH for study 1 was determined using an Accumat pH meter (Fisher 
Scientific, Ottawa, ON), whereas for studies 2 and 3 an Orion 3-Star pH meter (Thermo 
Scientific, Waltham, MA) was employed.  
3.5 Conductivity determination 
 Sample conductivity was measured using an Orion 3-Star conductivity meter 
with a dura probe 4 electrode conductivity cell (Thermo Scientific, Waltham, MA). 
 
3.6 Investigation of the phase behaviour of pea protein isolates–alginate mixtures 
as a function of pH and biopolymer mixing ratio (Study 1) 
 
3.6.1 Preparation of pea protein isolates 
Preparation of PPIn from PF was performed using methods modified from Bora 
et al. (1994). Briefly, approximately 400 g of PF was dispersed in 2.4 L of 50 mM 
phosphate (K2H2PO4) buffer (pH 7.20) containing 0.5 M NaCl at a ratio of 6 mL buffer 
to 1 g PF, with continuous stirring (Ikamag Ret-G, IKA Labortechnik, Germany) for 1 h 
at room temperature (21-23oC). The dispersion was centrifuged at 18,600 x g for 15 min 
at 4°C (Bechman J2-HC centrifuge; Bechman Coulter Canada Inc., Mississauga, ON). 
The pellet was discarded and the supernatant was decanted and filtered through glass 
wool to remove large residual particles. The resulting filtrate was diluted with 5 volumes 
of cold (4°C) ddH2O and adjusted to pH 4.50 using 2 N HCl. The solution was left to 
stand overnight to promote settling of the salt-soluble globulin proteins (e.g., legumin 
and vicilin). The majority of the solution was decanted to leave a concentrated protein 
slurry, which was then centrifuged (18,600 x g, 15 min, 4°C) to yield a protein-rich 
pellet. The pellet was washed with approximately 50 mL of ddH2O, followed by a 
second centrifugation. The resulting pellet was suspended in 50 mL of ddH2O and 
dialyzed (Spectro/Por tubing, 6-8 kDa limit, Spectrum Medical Industries, Inc., Rancho 





for the first 5 h and then twice a day until a conductivity of <1.5 µS/cm (~72 h) was 
reached. The de-salted protein solution was then freeze dried (Labconco Freezone 6 
Freeze dryer; Labconco Corporation, Kansas City, MO) for ~72 h. The resulting powder 
was a light tan colour and was sealed in a plastic screw capped 250 mL container and 
stored at -20oC.  
 
3.6.2 Turbidimetric acid pH titrations 
 Turbidimetric acid pH titrations of homogenous and mixed PPIn and AL systems 
were performed using the method of Liu et al. (2009) to identify critical structure 
forming events (pHc, pHφ1, pHopt and pHφ2), and, biopolymer and pH conditions where 
associative and segregative phase separation occurred. All analyses were made at room 
temperature and at a total biopolymer concentration of 0.1% (w/v). In brief, a PPIn stock 
solution was prepared by dissolving the powder in ddH2O, adjusting the pH to 8.00 
using 1 M NaOH, and stirring for 2 h at room temperature using a mechanical stirrer to 
help facilitate protein solubility. In the case of the AL stock solution, the powder was 
dissolved in ddH2O at room temperature for 30 min under constant mechanical stirring. 
Biopolymer solutions were mixed to obtain the following PPIn-AL (v/v) mixing ratios: 
1:1, 2:1, 4:1, 8:1, 12:1 and 20:1. After mixing solution pH was adjusted to pH 8.00 
using 0.1 N NaOH. Homogenous PPIn and AL solutions were prepared as controls, at 
the same protein (or polysaccharide) concentration used in the mixed system. For 
example, for the aforementioned PPIn-AL mixing ratios, homogenous PPIn 
concentrations were prepared at 0.050, 0.067, 0.080, 0.089, 0.920, and 0.095% (w/v), 
respectively. Acidification of the homogenous and mixed systems from pH 8.00 to 1.50 
was performed using a combination of 0.06% (w/v) glucono-δ-lactone (GDL) and a 
gradient of HCl. The internal acidifier (GDL) slowly lowers the pH from 8.00 to ~6.00 
followed by the drop wise addition of a gradient of HCl concentrations to minimize 
sample dilution:  0.05 M HCl for a pH >4.90; 0.5 M HCl for the pH range of 2.80 - 4.90; 
and 2 M HCl for the pH range of 1.50-2.80. Conductivity was monitored during 
turbidimetric experiments for mixing ratios of 1:1 and 20:1 PPI-AL. Changes in optical 
density (O.D.) over the experimental pH range of 7.00 to 1.50 was determined using a 





Lawn, NJ) at 600 nm employing 1 cm path length plastic cuvettes. Critical pHs 
corresponding to structure-forming events (pHc and pHφ1) were determined as the 
intersection between two curve tangents as described by Weinbreck et al. (2003a) and 
Liu et al. (2009). The pH where maximum O.D. occurred was denoted as pHopt. All 
turbidity profiles were prepared in triplicate, and the associated critical pH values were 
reported as the mean value ± one standard deviation. 
 
3.6.3 Electrophoretic mobility 
Electrophoretic mobility (UE), that is, the velocity of a particle within an electric 
field for homogenous and mixed PPIn-AL solutions were investigated as a function of 
pH (7.00-1.50) using a Zetasizer Nano-ZS90 (Malvern Instruments, Westborough, MA). 
Mixed systems were tested as a function of the biopolymer mixing ratio: 1:1, 2:1, 4:1, 
8:1, 12:1 and 20:1 PPIn-AL. Homogenous PPIn solutions were tested at concentrations 
of 0.050, 0.089 and 0.095% (w/v) which corresponded to the 1:1, 8:1 and 20:1 PPIn-AL 
mixing ratios. Alginate solutions were tested at a concentration of 0.050% (w/v) which 
corresponded to the 1:1 PPIn-AL mixing ratio. All samples were prepared (section 3.6.2) 
at a total biopolymer concentration of 0.1% (w/v), and were measured at room 
temperature. Solutions were acidified using an HCl concentration gradient as described 
in section 3.6.2, and were measured at 0.5 pH increments between pH 7.00 and 1.50. 









=       (eq.  5) 
 
where η was the dispersion viscosity, ε was the permittivity, and f(κα) was a function 
related to the ratio of particle radius (α) and the Debye length (κ). Using the 
Smoluchowski approximation, f(κα) was 1.5. All measurements were made in triplicate, 







A one-way analysis of variance (ANOVA) with a Scheffe post-hoc test was used 
to measure the statistical difference in state diagrams of critical pH values corresponding 
to structure forming events (pHc, pHφ1, and pHopt) as a function of the biopolymer 
mixing ratio. All statistical analyses were done using SPSS software (SPSS Inc., Ver. 
17, 2007, Chicago, IL). 
 
3.7 Entrapment of Bifidobacterium adolescentis within pea protein isolate–alginate 
capsules (Study 2). 
 
3.7.1 Microorganism 
 Bifidobacterium adolescentis ATCC 15703 (American Type Culture Collection, 
Manassas, VA) was chosen for this research because of its acid sensitivity and its ability 
to utilize FOS. The organism was stored at -70°C in a 1:1 (v:v) suspension of glycerol 
and MRS broth. The cultures were streaked onto RCM agar plates supplemented with 
0.05% (v/v) L-cysteine hydrochloride monohydrate (RCM-cys) and incubated at 37°C 
under anaerobic conditions (80% N2, 10% CO2, and 10% H2) using an anaerobic 
chamber (Forma Scientific Inc, Marietta, GA).    
 
3.7.2 Growth curve for Bifidobacterium adolescentis 
Growth experiments were conducted in RCM-cys broth to determine the time 
required for stationary growth to be reached; along with the corresponding cell 
concentrations. Side arm flasks containing 100 mL of RCM-cys broth (prepared 
according to manufacturer’s instructions) were autoclaved at 121°C for 15 min, and then 
placed in the anaerobic chamber to equilibrate overnight. Culture tubes was prepared by 
inoculating two pure colonies of B. adolescentis in 5 mL of sterile RCM-cys broth, 
followed by incubation at 37oC for 24 h under anaerobic conditions. A 100 µL aliquot of 
the starter culture was used to inoculate the side arm flask, which was incubated under 
anaerobic conditions for 40 h at 37oC. The optical density (600 nm) of the suspensions 





Scientific, Rockville, MD) every 40 min for 8 h (during the lag phase and start of the log 
phase of growth); every 20 min from 8-15.5 h (during the log phase of growth); and 
every 40 min from 15.5-21.5 h and then every hour from 21.5-26.5 h (during the 
stationary phase of growth). A final reading after 40 h of growth was also taken. 
Experiments were conducted in duplicate.  
Aliquots (100 µL) of suspensions were removed from the side arm flasks after 
15, 20, and 24 h of incubation and serially diluted with peptone saline (PS: 8.5 g/L NaCl 
and 1.0 g/L BactoTM Peptone). Cell concentrations were determined by spread plating 
onto RCM-cys agar plates. Cell counts were determined after 48 h of incubation at 37oC 
under anaerobic conditions. Experiments were conducted in duplicate. 
 
3.7.3 Preparation of Bifidobacterium adolescentis for encapsulation 
Two isolated colonies were inoculated into 5.0 mL of RCM-cys broth and 
incubated at 37°C under anaerobic conditions. After 20 h of growth (stationary phase), 
cells were harvested by centrifugation (1, 900 x g, 10 min at 4°C), washed with 
phosphate buffer saline (PBS; 0.01 M Na2HPO4, 0.137 M NaCl, 2.68 mM KCl, pH 7.0), 
centrifuged, and suspended in PS to a final cell concentration of 8-9 log CFU/mL. 
 
3.7.4 Encapsulation of Bifidobacterium adolescentis within PPIn-AL and PPIc-AL 
capsules 
This study was designed to test the effect of native versus commercial PPI as it 
related to both forming the capsule and protecting B. adolescentis during pH challenge 
experiments. Wall material solutions (prepared at 4:1 PPI-AL) for encapsulation of      
B. adolescentis were prepared using 2.0% (w/w) PPIn-0.5% (w/w) AL and 2.0% (w/w) 
PPIc-0.5% (w/w) AL mixtures. Capsules were prepared using slightly different 
procedures for PPIn and PPIc due to inherent differences in protein solubility. Capsule 
preparation methodologies were as follows: 
 (a) PPIn-AL capsules: Capsules were prepared using a modification of the 
method of (Krasaekoopt et al., 2003) based on an extrusion process. The wall material 





ddH2O at pH 8.00 with mechanical stirring for 2 h. The PPIn solution was then pH 
adjusted to 7.00 using 1 M HCl, followed by the addition of the required amount of AL. 
The resulting solution was heated to 80oC for 30 min, and then cooled to room 
temperature in a water bath. The final solution was corrected (by weight) for water loss 
during heating by the addition of ddH2O. A mixture containing 1.0 g of washed B. 
adolescentis cells in PS (8-9 log CFU/mL) and 18.0 g of the prepared 2.0% (w/w) PPIn-
0.5% (w/w) AL solution was first mixed, then extruded by hand through a 20 gauge (G) 
needle (25.4 mm in length, 0.584 mm internal diameter; BD, Sparks, MD) and dropped 
30 mm into 30 mL of a filter sterilized cross-linking solution (1.0% CaCl2 + 1.0% (w/v) 
Tween 80). The resulting capsules were mechanically stirred (150 rpm) for 30 min at 
room temperature to afford hardening, and were then washed twice with PS by 
decanting. Capsules were used immediately after preparation in survivability studies. 
Encapsulation experiments were performed in triplicate.  
 (b) PPIc-AL capsules: Capsules were prepared by dispersing PPIc (weight 
adjusted for protein content) in 80 g of ddH2O, followed by pH adjustment to 10.00 with 
1.0 M NaOH. The resulting mixture was heated to 80oC with constant mechanical 
stirring for 30 min.  The resulting solution was allowed to cool to room temperature 
using a water bath and neutralized to pH 7.00 using 1 M HCl. Alginate powder was 
added, followed by heating at 80oC for 30 min with constant mechanical stirring. The 
resulting biopolymer mixture was cooled to room temperature using a water bath, 
followed by addition of ddH2O to correct for water loss (by weight) during heating. The 
mixing of the wall material with B. adolescentis cells, and capsule formation was 
identical to the procedures presented in section (a). Encapsulation experiments were 
performed in triplicate. 
 
3.7.5 Survival of free and encapsulated Bifidobacterium adolescentis in simulated 
gastric juice at pH 2.0 
 The ability of free and encapsulated B. adolescentis to survive in simulated 
gastric juice (SGJ; 0.08 M HCl and 0.2% NaCl (w/v)) were tested at pH 2.0 (Rao et al., 
1989). Aliquots of 0.5 mL of free or encapsulated cells (8-9 log CFU/mL) in PS were 





incubated at 37°C for 2 h. Aliquots (0.5 mL) of free or encapsulated cells were removed 
every 5 min for the first 30 min, and then every 30 min for a total of 2 h. Once removed 
from the incubator, the samples were neutralized to pH 7.0 using 0.05 M NaOH and 
transferred into 9.5 mL of PS. For encapsulated systems, samples were homogenized 
(Omni International Inc., Marietta, GA) at 9,000 rpm for 30 s to break up the capsule 
wall. To quantify the number of surviving bacteria, aliquots of the culture medium were 
serially diluted in PS and spread plated onto RCM-cys agar. The plates were incubated 
at 37°C in an anaerobic chamber for 48 h and enumerated. A D-value was determined 
which represents the amount of time for 1-log reduction in cell numbers to occur. The 
D-value was calculated using the equation, D = t/n where n = (log No-log Nt) = 1 log10 
reduction of the cells number, D = Decimal reduction time (min) at pH 2.0, No= bacteria 
at 0 time, Nt = surviving bacteria after an exposure time, t (min) (Kotikalapudi et al., 
2010). These experiments were performed in triplicate.  
 
3.8 Encapsulation of Bifidobacterium adolescentis within PPIc-AL capsules: effect 
of wall characteristics and processing conditions on wall physical properties and 
their protective nature (Study 3)  
 
3.8.1 Effect of biopolymer concentration and mixing ratio, prebiotic levels and 
needle gauge size on the PPIc-AL capsule design 
 Capsules were prepared using a similar method as described in section 3.7.4, 
with the following total biopolymer concentration and mixing ratios: 2.5% (w/w) (2.0% 
PPIc-0.5% AL – or 4:1), 4.5% (w/w) (4.0% PPIc-0.5% AL – or 8:1) and 6.5% (w/w) 
(6.0% PPIc-0.5% AL – or 12:1). The prebiotic (FOS) concentrations used were; 0, 0.19 
(1.0%), 0.38 (2.0%), and 0.57 (3.0%) g, and the needle gauge sizes were 20G (0.584 
mm i.d.) and 27G (0.191 mm i.d.). Bacterial cells, biopolymer mixture and prebiotic 
were mixed together prior to extrusion. All capsule designs were prepared in triplicate 






3.8.2 Capsule size 
Wet capsules containing B. adolescentis were sized using a laser scattering 
particle size distribution analyzer (PSA) (Horiban Instruments Inc., Irvine, CA). The 
PSA measures particle size distributions between 0.01-3000 µm by laser diffraction to 
determine particle geometric mean and variance. All experiments were done in 
duplicate. 
 
3.8.3 Capsule protein content 
Protein retention within the capsule following cross-linking was determined by 
measuring protein levels present in the cross-linking and wash solutions post cross-
linking using the Bradford protein assay (Bradford, 1976). Capsules were prepared in a 
similar manner as outlined in section 3.8.1 with the exception of the absence of B. 
adolescentis. Following 30 min of hardening, the cross-linking and wash solutions were 
vacuum filtered (12.5 cm diameter filter paper; VWR 417, VWR International, 
Edmonton, AB) to remove particulates. The filtrates were collected, pooled and brought 
to a final volume of 50 mL using ddH2O. A 100 µL aliquot of this solution was added to 
5.0 mL of Bio-Rad protein assay dye reagent (Coomassie brilliant blue   G-250 dye) in a 
glass test tube (18 mm x 150 mm) and vortexed for 10 s. The sample was incubated at 
room temperature for 10 min and the absorbance read at 595 nm using a Genesys 20 
visible spectrophotometer (Thermo Fisher Scientific, Waltham, MA). A blank was 
prepared in the same fashion as the sample, without protein (i.e., only AL and 
prebiotics). Similar to the samples, 18 g of the blank solution was extruded into the 
cross-linking solution (30 mL) and was allowed to harden for 30 min. This solution (i.e., 
AL, prebiotics, and cross linking solution) was then homogenized at 9,000 rpm for 1 
min. A standard curve was prepared with bovine serum albumin (BSA) at a 
concentration range of 0.04-0.9 µg/µL with correlation coefficients of 0.9908 or greater. 






3.8.4 Capsule prebiotic content 
Prebiotic (FOS) retention within the capsule following cross-linking was 
determined by measuring prebiotic levels present in the cross-linking and wash solutions 
post cross-linking using HPAEC-PAD.  Capsules were prepared in a similar manner as 
outlined in section 3.8.1 with the exception of the absence of B. adolescentis. Following 
30 min of hardening, the cross-linking and wash solutions were vacuum filtered to 
remove particulates. The filtrates were collected, pooled and brought to a final volume 
of 50 mL using ddH2O. A 3.0 g aliquot of this solution was hydrolyzed by the addition 
of 1.5 g of 6 N HCl with constant mechanical stirring for 18 h at room temperature. 
After hydrolysis, the samples were neutralized to pH 7.00 with   1.0 M NaOH and 
brought to a total volume of 10 mL using ddH2O. The samples were diluted with ddH2O 
for HPAEC analysis, 1/20 (0.19 g FOS), 1/35 (0.38 g FOS), and 1/50 (0.57 g FOS). The 
amount of FOS entrapped was determined by comparison to a single point standard for 
each FOS concentration. A standard solution was prepared containing 30 mL of cross-
linking agent, 0.19, 0.38 or 0.57 g of FOS, and was brought to volume (50 mL) with 
ddH2O. The standard solution was hydrolysed, neutralized, and diluted under the same 
conditions as the sample. Sample analysis was performed using HPAEC-PAD (section 
3.3). In this work an isocratic mobile phase of 100 mM NaOH was used. The flow rate 
was maintained at 1.0 mL/min and the column pressure was approximately 1200 psi. 
Experiments were conducted in triplicate. 
An estimate of the number of capsules prepared per gram was determined for a 
2.0% (w/w) PPI-0.5% AL material extruded through both a 20 G and 27 G needle, 
through manual counting. Capsules were prepared in a similar manner as outlined in 
section 3.8.1, except in the absence of B. adolescentis. Capsules were first vacuum 
filtered and dry blotted using Kim wipes (Kimberly-Clark Professional, Huntsville, 
Ontario), weighed (1 ± 0.0002 g) and counted. Three separated batches were prepared, 
with data reported as the mean ± one standard deviation. 
 
3.8.5 Capsule weight change in simulated gastric juice at pH 2.0 
 The swelling properties of freshly prepared capsules within SGJ were 





37oC to represent gus residence time. Capsules were prepared as outlined in sections 
3.7.4 and 3.8.1, except in the absence of B. adolescentis. In brief, ~ 1 ± 0.0002 g of 
capsules that had been dry blotted using Kim wipes (Kimberly-Clark Professional, 
Huntsville, Ontario) were added to a glass test tube (18 mm x 150 mm) containing 5.0 
mL of tempered SGJ at 37oC for 2 h. Samples were vacuum filtered, dry blotted, and 
weighed to determine weight gain/loss after SGJ treatment. All experiments were 







WWRatioSwelling −=      (eq.  6) 
 
where, W1 was the initial weight of the capsules prior to SGJ treatment and W2 was the 
final weight after SGJ treatment for 2 h.  
 
3.8.6 Survival of free and encapsulated cells in simulated gastric juice at pH 2.0. 
 Experiments were performed as outlined in section 3.7.5, and were conducted in 
triplicate.  
 
3.8.7 Probiotic release in simulated intestinal fluid 
 The ability of encapsulated B. adolescentis to be released from PPIc-AL capsules 
(2.0% PPIc-0.5% AL with 0% and 3.0% FOS and 20G; and 6.0% PPIc-0.5% AL with 
0% and 3.0% FOS and 20G) within simulated intestinal fluid (SIF; 1.25% (w/v) 
NaHCO3, 0.6% (w/v) oxgall dehydrated fresh bile, and 0.09% (w/v) pancreatin) was 
tested using methods modified from Laird (2007). Capsule parameters were selected 
based on extreme conditions for amount of protein and prebiotic within the capsule. A 
20 G needle was used due to small difference in size produced during encapsulation and 
size did not affect survival of probiotics during SGJ experiments. Aliquots of 1.0 mL of 
free or encapsulated cells (8-9 log CFU/mL) in PS were added to 19.0 mL of tempered 





chamber. Aliquots of 1.0 mL were removed every 30 min for 3 h and serially diluted in 
PS. Cell concentrations were determined by spread plating onto RCM-cys agar plates 
and enumerated after 48 h of incubation in an anaerobic chamber (37°C). Samples were 
performed in triplicate.    
 
3.8.8 Statistics 
An analysis of variance (two-way ANOVA) was used to statistically compare 
differences in capsule size, swelling, and protein/prebiotic retention as a function of 
protein concentration, prebiotic levels and needle gauge. All statistical analyses were 






4. Results and Discussion 
4.1 Material characterization 
 Pea flour was found to be comprised of 21.78% protein (%N x 6.25), 7.80% 
moisture, 1.00% lipid, 4.16% ash and 65.26% carbohydrate; PPIn was comprised of 
93.50% protein (%N x 6.25), 1.55% moisture, 2.40% lipid, 0.79% ash and 1.76% 
carbohydrate; and PPIc was comprised of 80.01% protein (%N x 6.25), 2.60% moisture, 
1.81% lipid, 4.79% ash and 10.78% carbohydrate. Gwiazda et al. (1980) reported 
protein levels in their salt extracted pea protein isolate to be 89.10%. Whereas, Sun and 
Arntfield (2011) reported levels to be 81.90%) for their pea protein isolate extracted 
from pea flour by salt extraction. The authors reported similar levels, 82.00% in the 
commercial pea protein isolate. In the case of AL, the powder was found to be 
comprised of 0% protein, 13.03% moisture, 0.10% lipid, 24.35% ash and 62.52% 
carbohydrate. The HPAEC-PAD analysis of fructooligosaccharide P95 indicated peaks 
within the chromatogram corresponding to glucose, fructose, sucrose and 
oligosaccharides of varying degrees of polymerization (DP) (Figure 4.1). Specifically, 
inulobiose (DP = 2), inulotriose (DP = 3), inulotetraose (DP =4), inulopentaose (DP = 
5), inulohexaose (DP = 6), and inuloheptaose (DP = 7). Peaks present in between the 
identified peaks (Figure 4.1) contain a terminal glucose end. Wood (2010) reported a 
similar profile for P95 which contains oligosaccharides ranging between DP 2 to 7 with 
DPs constituted with a fructose as well as those with a terminal glucose. 
 
4.2 Investigation of the phase behaviour within pea protein isolates (PPIn)-alginate 
mixtures as a function of pH and biopolymer mixing ratio (Study 1) 
 
4.2.1 Effect of pH and biopolymer mixing ratio on complex coacervation 
 The effect of pH (1.50-7.00) and biopolymer mixing ratio (1:1-20:1 PPIn-AL) on 
complex formation was investigated in admixtures of PPIn and AL at a constant total 















Figure 4.1 HPEAC-PAD carbohydrate profile for fructooligosaccaride P95 (G-
glucose,   F-fructose, S-sucrose, DP 2-7 with DP 2-6 included FOS 
structures of Gα 1→2 [βF 1→2]n and [βF 1→2]n n = 2-7 (i.e., DP 2 





In the case of homogenous PPIn solutions, O.D. was followed as a function of pH over a 
concentration range (0.050-0.095%, w/w) (at levels corresponding to those used in the 
mixed systems). At all concentrations, O.D. were found over a pH range between ~2.00 
and 6.00, with a broad peak occurring between ~pH 3.40–4.30 (median pHopt ~3.80) 
(Table 4.1, Figure 4.2a). However, the peak O.D. was found to increase from 0.500 at 
0.05% (w/v) PPIn, to 0.950 at 0.095% (w/v) PPIn. The rise in O.D. during the pH 
titration is thought to be attributed to an increase in protein-protein aggregation 
associated with reduced charge repulsion between neighbouring protein molecules near 
the protein’s isoelectric point (pI ~3.84-4.23; zeta potential = 0 mV) (Figure 4.2b). At 
solution pH>pI, proteins assume a net negative charge (zeta potential <0 mV), whereas 
at pH<pI proteins assume a net positive charge (zeta potential >0 mV) (Figure 4.2b).  
Harnsilawat et al. (2006) also observed protein-protein aggregation when investigating   
β-lactoglobulin. The protein had increased turbidity at pH 4.00 and 5.00, which 
corresponds to the protein’s pI (pI ~4.80).  In the current study a small concentration 
effect on pI was seen. At PPIn levels of 0.050% (w/v) the pI occurred at 3.84, while at 
PPIn levels of 0.089% and 0.095% (w/v), pI values were both equivalent to 4.23. 
Concentration related deviations in pI values may be the result of different levels of 
exposed charged amino acids on the surface, a consequence of increased protein-protein 
aggregation at higher concentration levels. Liu et al. (2009) reported that a homogenous 
PPIn (prepared using the method of Crevieu et al. 1996) showed optimal O.D. near pH 
4.00 which was similar to the present study, however their pI value was slighter higher 
(pI 5.60) then found in the current study. The differences in pI values between the two 
studies may reflect slight differences in the methods used during protein extraction from 
the PF.  In the case of homogenous AL solutions, no O.D. was measured over the 
complete pH range (Figure 4.2a). The surface charge on the AL chain remained negative 
over the complete pH range measured, however it approached a zeta potential of 0 mV 
close to pH 1.50. At this pH, carboxyl groups along the AL backbone become 
protonated (Liu et al., 2009). Harnsilawat et al. (2006) reported similar  O.D. and 
surface charge behavior for AL chains, where no O.D. was observed over a pH range of 
3.00 to 7.00 indicating the absence of aggregates, and that AL remained negatively 










Table 4.1 Solution pHs corresponding to maximum O.D. values for homogenous 
PPIn solutions as a function of protein concentration, and in mixed 
PPIn–AL systems as a function of biopolymer mixing ratio (total 
concentration of 0.1% (w/v)). Data represent the mean values ± one 
standard deviation (n = 3).  
 pH range of pHopt Median pHopt value 
 Lower Upper  
Homogeneous                
PPIn (%, w/v)1 
  
0.050 3.53 ± 0.21 4.16 ± 0.22 3.84 ± 0.21 
0.067 3.43 ± 0.22 4.13 ± 0.21 3.78 ± 0.21 
0.080 3.59 ± 0.27 4.30 ± 0.44 3.95 ± 0.33 
0.089 3.61 ± 0.19 4.16 ± 0.19 3.88 ± 0.18 
0.092 3.47 ± 0.16 4.03 ± 0.21 3.75 ± 0.18 
0.095 3.50 ± 0.10 3.99 ± 0.17 3.75 ± 0.13 
Mixed PPIn -AL Ratios    
1:1 1.89 ± 0.11 2.30 ± 0.10 2.10 ± 0.09 
2:1 1.97 ± 0.12 2.73 ± 0.06 2.35 ± 0.09 
4:1 2.33 ± 0.12 3.17 ± 0.06 2.75 ± 0.05 
8:1 2.83 ± 0.15 3.38 ± 0.11 3.11 ± 0.13 
12:1 3.00 ± 0.10 3.55 ± 0.28 3.28 ± 0.17 
20:1 3.00 ± 0.17 3.67 ± 0.25 3.33 ± 0.21 
1 PPIn concentrations used in the homogenous solutions correspond to protein levels found in the 







Figure 4.2 Mean turbidity profiles (a) and zeta potential, mV (b) curves for 
homogenous PPIn and AL solutions as a function of pH and 





 another carboxylated polysaccharide, no rise in O.D. was found over the pH range 1.50-
7.00, and that net neutrality occurred at pH 1.88.   
The addition of AL to a PPIn solution, at a 1:1 biopolymer mixing ratio caused a 
significant shift in the initial rise in turbidity from ~pH 6.00 for PPIn alone to pH 5.00 
for the PPIn-AL mixture (Figures 4.2a, 4.3). This shift was also accompanied by a much 
slower rise in O.D. during the pH titration, where large increases in O.D. were not seen 
until pH 3.00 (Figure 4.3) compared with pH 5.00 in the homogenous PPIn sample 
(Figures 4.2a). In addition, a slightly lower maximum O.D. was found in the mixed 
system than the homogenous one, which occurred at a pH near 2.50 instead of 4.00. The 
pH-dependent turbidity profiles of the PPIn-AL mixture appeared skewed leftwards 
(Figure 4.3), whereas the curve for homogeneous PPIn had a normal distribution (Figure 
4.2a). It was hypothesized that the presence of the highly charged polysaccharide AL at 
a concentration of 0.05% (w/w) caused sufficient electrostatic repulsion to delay protein 
aggregation and the slight reduction in maximum O.D. may correspond to a small 
inhibition of structure formation (i.e., protein-protein aggregates).  
 As the PPIn-AL mixing ratio increased (i.e., PPIn levels increased; AL levels 
decreased), the delay in aggregate growth as a function of decreased pH was less 
substantial. Furthermore, the nature of the turbidity profiles more became normally 
distributed as the mixing ratio increased (Figure 4.3). Admixtures at ratios between 8:1 
and 20:1 had overlapping turbidity profiles suggesting the PPIn levels were in excess of 
the carboxyl reactive sites along the AL backbone (Figure 4.3). The shift to maximum 
O.D. at lower pHs with the addition of AL suggest structures with increased stability at 
acidic pHs relative to homogeneous PPIn aggregates. Similar trends were reported by 
Liu et al. (2009) for admixtures of PPIn and gum Arabic where at a biopolymer ratio 
>4:1 turbidity profiles became constant. The authors also reported enhanced aggregate 
stability at acidic pH (pH<3.10) relative to PPIn alone. Schmitt et al. (1999) also 
reported similar findings for β-lactoglobulin-acacia gum when both acacia gum (1:6-
1:20) and β-lactoglobulin (6:1-50:1) were in excess. 
 Critical structure forming events associated with the formation of soluble and 
insoluble complexes in a 1:1 PPIn-AL mixture were found to occur at pH 5.00 ± 0.159 













Figure 4.3 Mean turbidity profiles for mixtures of PPIn-AL as a function of pH 





occurring at pH 2.10  ± 0.090 (pHopt). A two-step mechanism for coacervation has been 
previously reported for WPI-gum Arabic (Weinbreck et al., 2003a), WPI-EPS B40 
(Weinbreck et al., 2003b), WPI-carrageenan (Weinbreck et al., 2004a), β-lactoglobulin-
pectin (Girard et al., 2004), gelatin-agar (Singh et al., 2007), and PPI-gum Arabic (Liu et 
al., 2009). This two stage formation is thought to follow nucleation and growth-type 
kinetics (Turgeon et al., 2003); first with the formation of soluble complexes which act 
as nucleation sites; and second by an increase in both size and number of complexes in 
suspension. The increase in size and number of the complexes leads to the formation of 
insoluble complexes and phase separation into coacervate-rich (or precipitate-rich) and 
solvent-rich phases.  
As biopolymer mixing ratios increased in the current study, critical pH values 
(pHc, pHφ1 and pHopt) shifted towards higher pH until a biopolymer mixing ratio of 
between 4:1 and 8:1 (p<0.05) was reached. Above that ratio a plateau was reached 
where critical pHs became independent of mixing ratios up to 20:1 (p>0.05) (Figure 
4.4). Maximum O.D. at pHopt was found to increase from 0.573 at a 1:1 PPIn-AL ratio to 
0.857 at the 4:1 ratio (p<0.05), and then became constant at ratios >4:1 (p>0.05) (Figure 
4.5). Complete dissolution of complexes at pHφ2 could not be identified in the present 
study due to enhanced structure stability at acidic pHs in the presence of AL which 
prevented the O.D. from reaching the baseline. However, a sharp decrease in O.D. at 
pH<pHopt indicates that partial dissolution of the formed complexes occurred with some 
dissolution of the protein subunits under acidic conditions (Figure 4.4) (Gueguen et al., 
1988). Gueguen et al. (1988) investigated the dissociation and aggregation of pea 
legumin induced by pH and ionic strength. They reported at both extreme acidic (<3.00) 
and basic (>11.00) pH most of the molecules were dissociated and at acidic conditions 
(pH <3.00) the native structure was completely dissociated leading to completely 
unfolded subunits. Liu et al. (2010b) studied the effect of NaCl, urea, and elevated 
temperature on the nature of the intramolecular interactions within PPI-gum Arabic 
mixtures. The authors reported electrostatic interactions were primarily responsible for 
the complex formed, with secondary stabilization by hydrogen bonding. Complexes 













Figure 4.4 Critical pH values associated with the formation of soluble (pHc) and 
insoluble (pHφ1) complexes, and optimal biopolymer interactions 
(pHopt) as a function of biopolymer mixing ratio for PPIn-AL mixtures. 













Figure 4.5 Maximum optical density at pHopt in admixtures of PPIn-AL as a 
function of biopolymer mixing ratio. Data points represent the mean ± 





individual PPI molecules. Within the O.D. vs. pH profiles a shoulder was present at 
acidic pHs (pH <3.00) indicating improved stability at lower pH. As pH was lowered 
further complexes dissociated. The shoulder and enhanced stability was hypothesized by 
the authors to be related to hydrophobic interactions that stabilized the PPI-PPI 
aggregates. At higher temperatures, stability and the shoulder were enhanced which 
supported their claim. In contrast to Liu et al. (2010b), AL was used in the present study 
due to its stronger electrostatic interactions with PPI which should lead to a more intact 
capsule. Similar to Liu et al. (2010b), complexes are thought to be comprised of AL 
bound to PPI-PPI aggregates, which are further stabilized by hydrogen bonding and 
hydrophobic interactions. 
In the current study, pHc was found to be somewhat dependent on the 
biopolymer mixing ratio. As biopolymer mixing ratio increased up to a mixing ratio 
between 4:1 and 8:1, a shift in pHc to higher pH values was seen, after which a plateau 
was reached. The biopolymer mixing ratio dependence of pHc has been previously 
reported for PPI-gum Arabic (Liu et al., 2009) and gelatin (Type-A and Type-B)-agar 
(Singh et al., 2007) systems. Liu et al. (2009) reported similar results for PPI-gum 
Arabic mixtures, that pHc was dependent upon biopolymer mixing ratio up to a ratio of 
4:1 (PPI-gum Arabic) after which pHc remained constant. They reported that the shift in 
pHc toward higher pHs with increased mixing ratio was caused by the interactions 
between gum Arabic and protein-protein aggregates rather than a single protein 
molecule. They also reported that the protein-protein aggregates increased in size as the 
mixing ratio increased up to the critical limit. Afterwards, pHc values remained constant. 
However, these pHc-mixing ratio dependent trends are contradictory to results found in 
other literature. For instance, in systems such as bovine serum albumin-polyelectrolyte 
poly(dimethyl diallyl ammonium chloride) (Mattison et al., 1995), whey protein-
exocellular polysaccharide B40 (Weinbreck et al., 2003a,b), whey protein-carrageenan 
(Weinbreck et al., 2004a), and lactoglobulin (aggregate-free)-pectin (Girard et al., 
2004), a constant pHc as a function of biopolymer mixing ratio was reported. These 
authors report that the lack of pHc ratio dependence is caused by complexes formed 
comprised of a single polysaccharide with only a given amount of proteins. In all cases, 





contrast to the present study where homogeneous protein solutions showed significant 
O.D. between the pH range 2.00 and 6.00, which overlapped with the mixed turbidity 
profiles; these authors reported the lack of O.D. within the homogenous samples once 
the protein aggregates were removed. 
In the case of pHφ1, the mixing ratio dependence is quite prevalent. Weinbreck 
and co-workers (2003a, b) and Liu et al. (2009) reported a shift in pHϕ1 towards higher 
pH until a critical biopolymer mixing ratio was reached, beyond which pHϕ1 became 
stable. The increase in pHϕ1 with increasing biopolymer mixing ratio was thought to be 
due to a greater amount of protein molecules available per polysaccharide chain after 
which it becomes stable due to a saturation of the polysaccharide (Liu et al., 2009). Liu 
et al. (2009) reported after a 4:1 mixing ratio there was saturation of gum Arabic.  
Changes to O.D. reported in this study during the pH titration were not believed 
to be associated with changes to conductivity or dilution effects caused by the addition 
of HCl during the pH titration. Changes to conductivity were similar regardless of the 
mixing ratio. For instance, for the 1:1 mixing ratio, conductivity increased from 167.2 
µS/cm at pH 7.00 to 19,910 µS/cm at pH 1.50, whereas for the 20:1 mixing ratio, 
conductivity rose from 160.7 µS/cm at pH 7.00 to 18,050 µS/cm at pH 1.50.  Although a 
large increase in conductivity was observed as pH decreased (1.50), solution 
conductivity corresponding to the pH range where structure forming events (pHc, pHφ, 
and pHopt) occurred remained low (<600 µS/cm). The 1:1 mixing ratio however, due to 
the shift in critical pH values towards a lower pH had a slightly higher conductivity at 
pHφ1 (pH 2.30) at 2478 µS/cm compared with the 20:1 mixing ratio. Dilution effects 
were also kept to a minimum by using an HCl concentration gradient to acidify the 
solution only <600µL of HCl was added to the total volume. 
Changes to the surface charge were also investigated as a function of pH during 
a similar acid titration as the turbidity profiles, and as a function of biopolymer mixing 
ratio (Figure 4.6). The addition of AL to PPI caused a shift of net neutrality from ~4.00 
with homogenous PPIn to ~1.55 at the 1:1 PPI-AL ratio. The 1:1 biopolymer mix ratio 
displayed similar electrophoretic mobility as the homogenous AL solution (Figures 4.2b, 
4.6), where homogenous AL retained a negative charge (zeta potential <0 mV) over 







Figure 4.6 Mean zeta potential (mV) profiles for mixtures of PPIn-AL as a 
function of pH and biopolymer mixing ratio (PPIn-AL) (a), and the 
isoelectric points (pI) of formed complexes as a function of biopolymer 





for AL (0.1 wt%), where the zeta potential remained negative over a pH range of 2.00 to 
8.00 (-8.7 to -68.4 mV). The authors reported slightly higher zeta values between pHs 
2.00 and 4.00, relative to higher pHs since carboxyl groups (-COO-) along the AL 
backbone were becoming protonated (-COOH). Ducel et al. (2004) also reported a 
negative surface charge for AL over the pH range of 2.20 to 4.50, with an increase in 
zeta potential from ~ -60 mV to -20 mV during the pH titration towards pH of 2.20. 
Similar findings were reported by Liu et al. (2009) and Weinbreck et al. (2004b) for 
another carboxylated polysaccharide, gum Arabic. Both groups reported pI values of 
gum Arabic between 1.88 and 2.00. In the current study, as protein levels increased (i.e., 
as the mixing ratio increased), the pH corresponding to net neutrality shifted towards 
higher pHs until the ratio reached 8:1 PPIn-AL ratio after which it then became constant 
at a pH of 3.65. As in the turbidity profiles shown in figure 4.3, mixing ratios between 
8:1 and 20:1 behaved similarly, and resembled that of the individual PPI molecules. 
Within the O.D. vs. pH profiles a shoulder was present at acidic pHs (pH <3.00) 
indicating improved stability at lower pH. As pH was lowered further complexes 
dissociated. The shoulder and enhanced stability was hypothesized by the authors to be 
related to hydrophobic interactions that stabilized the PPI-PPI aggregates. At higher 
temperatures, stability and the shoulder were enhanced which supported their claim. In 
contrast to Liu et al. (2010b), AL was used in the present study due to its stronger 
electrostatic interactions with PPI which should lead to a more intact capsule. Similar to 
Liu et al. (2010b), homogenous systems at corresponding concentrations (Figure 4.2a). 
At or above the 8:1 PPIn-AL ratio, it was assumed that reactive sites along the AL had 
become saturated (Liu et al., 2009). In all cases, pH corresponding to net neutrality (zeta 
potential = 0 mV) was close to pHopt values at the associated biopolymer mixing ratio 
(within one pH unit difference) (Figures 4.3 and 4.5) suggesting that at pHs near pHopt, 
charge neutralization was occurring. For instance, pHopt for the 8:1 ratio was reported to 
occur at pH ~3.00, while net neutrality was found at pH ~3.80. At pHs above net 
neutrality, PPI-AL complexes carried a net negative charge, whereas at lower pH, 
complexes carried a positive net charge. Liu et al. (2009) reported net neutrality of 







 The effect of pH and biopolymer mixing ratio on the formation of soluble and 
insoluble complexes between PPIn and AL were investigated. Based on the turbidity 
profiles (Figure 4.3), critical pHs associated with structure forming events (pHc, pHφ1 
and pHopt) (Figure 4.4), maximum O.D. at pHopt (Figure 4.5), and electrophoretic 
mobility (Figure 4.6), optimum conditions for coacervation were thought to occur at a 
biopolymer mixing ratio of 4:1 and at solution pH near 2.75. 
 In the next stage of this research the encapsulation of probiotic bacteria            
(B. adolescentis) within a PPI-AL capsule will be investigated. However, the 
coacervation of PPI-AL mixtures is optimal under acidic conditions (pH 3.00), these 
pHs are not congruent to support probiotic survival. Consequently mixtures will be 
developed at suitable pH (7.0) relying on segregative (non-interacting) conditions to 
prepare the capsule wall, with the addition of Ca2+ salts to induce ionic cross-linking 





4.3 Entrapment of Bifidobacterium adolescentis within pea protein isolate–alginate 
capsules (Study 2) 
 
4.3.1 Growth profile of B. adolescentis in RCM-cys media 
Growth of B. adolescentis within RCM-cys broth was followed over a 40 h 
duration to determine times associated with various stages of growth (i.e., lag, 
exponential and stationary phases) (Figure 4.7). Changes in O.D. at 600 nm indicated 
that the lag phase of growth ranged between 0 and 5 h, followed by exponential growth 
between 5 and 15 h. The stationary phase of growth for B. adolescentis was from 15 to 
~20+ h, which corresponded to an O.D. magnitude of 1.500 and cell numbers as 
determined by pour plating to be 9 log CFU/mL. Work by Wood (2010) on growth 
profiles of B. adolescentis over a similar time period found the stationary phase of 
growth to range between 15 and 27 h, where cell numbers also remained stable at 9 log  
CFU/mL. In the past, cells harvested during the stationary phase of growth have shown 
the greatest survival during the encapsulation process (Hansen et al., 2002; Masco et al., 
2007). Masco et al. (2007) investigated 66 Bifidobacterium strains in both exponential 
and stationary phase growth for their tolerance to in vitro gastrointestinal transit. The 
authors reported there was enhanced tolerance when the cells were in the stationary 
phase compared to the exponential phase. Based on findings from this study, B. 
adolescentis grown for the purposes of entrapment will be harvested during the 
stationary phase (15 to 20 h) prior to encapsulation.  
 
4.3.2 Survival of free and encapsulated Bifidobacterium adolescentis within 
simulated gastric juice  
The survival of B. adolescentis within SGJ at pH 2.0 and 37°C was investigated 
for non-encapsulated cells (denoted as ‘free’ cells) and those entrapped within PPIn-AL 
and PPIc-AL based capsules (Figure 4.8). Free B. adolescentis cells experienced a large 
log cycle reduction in cell numbers within the first 5 min of being submerged in SGJ, 















Figure 4.7 Growth curve of B. adolescentis grown in RCM-cys broth over time. 












Figure 4.8 Survival of free B. adolescentis and entrapped within PPIn-AL and 
PPIc-AL capsules (2.0% PPI-0.5% AL; or 4:1 mixing ratio) over time 
within simulated gastric juice at pH 2.0 and 37°C. Data points 





min exposure (Figure 4.8). A D-value was calculated within the first 5 min of exposure 
to SGJ due to drastic decrease in viable cells numbers. Kotikalapudi et al. (2010) 
reported a similar D-value for free B. adolescentis exposed to SGJ (pH 2.0). They 
reported that rapid depletion of viable free cells occurred within the first 5 min of 
exposure, with a D-value 1.12. Free B. adolescentis cell counts in the current study 
reached the lower limit of detection (102 CFU/mL) after 25-30 min of exposure to SGJ. 
In contrast, entrapped B. adolescentis cells within the PPIn-AL and PPIc-AL capsules 
provided almost complete protection of the cells from SGJ over a 2 h period. Only a 1-
log reduction in cell numbers from 109 to 108 CFU/mL (D-value 67.99, calculated at 120 
min) was observed for PPIn-AL capsules and less than 1 log reduction for PPIc-AL 
capsules (no D-value was calculated since there was less than a 1 log decrease in 
CFU/mL) (Figure 4.8). Kotikalapudi et al. (2010) showed that encapsulating probiotic L. 
acidophilus within a PPI-AL mixture, improved survival by ~6 times relative to non-
encapsulated cells during exposure to SGJ at pH 2.0. Wood (2010) encapsulated B. 
adolescentis within AL, PPI-AL, and WPI-AL capsules. Survival following exposure to 
SGJ (pH 2.0) was similar to free cells for the AL capsules, however, PPI-AL and WPI-
AL capsules improved survival of entrapped cells. Wood reported the PPI-AL and WPI-
AL capsules were less porous than the AL capsules which slowed the diffusion of SGJ 
across the capsule wall. Higher concentrations of wall material also were added in the 
protein-AL capsules compared to AL alone. More wall material created a denser capsule 
structure which would also have slowed diffusion of SGJ into the capsule. 
 
4.3.3 Summary 
 Findings from study 2 suggest that the designed PPI-AL capsules offer highly 
effective protection against the acidic environment within the gastrointestinal tract, with 
no difference in protective effect between capsules prepared using PPIn versus PPIc. 
Utilization of PPIc instead of PPIn in capsule design could offer tremendous 
opportunities for product design scale up, due to the greater cost and availability 
challenges in obtaining a more native (i.e., non-denatured) commercial pea protein 






4.4 Encapsulation of Bifidobacterium adolescentis within PPIc-AL capsules: effect 
of wall characteristics and processing conditions on the physical properties and the 
protective nature of the capsules (Study 3)  
 
4.4.1 Capsule size and size distribution 
A particle size analyzer was used to investigate the effect of needle gauge (20 
and 27 G), PPI protein concentration (2.0, 4.0, and 6.0% w/w plus 0.5% w/w AL), and 
prebiotic (FOS) concentration (0, 1.0, 2.0, and 3.0%, w/w) on mean capsule size 
produced in the presence of B. adolescentis. Capsules were formed after extrusion of the 
biopolymer solution through the needle and dropping 30 mm into a cross-linking bath 
containing 1.0% (w/w) CaCl2 and 1.0% (w/v) Tween 80. For all materials and extrusion 
conditions, capsule diameter (or size) followed a non-Gaussian distribution and were 
reported as the geometric mean bead diameter. Figure 4.9 gives a typical capsule size 
distribution profile for a 2.0% PPIc-0.5% AL system at a 1.0% (w/w) prebiotic level, 
extruded through both 20 and 27 G needles. For both needle diameters, the size 
distributions of the capsules are skewed slightly towards the right or towards larger 
sized capsules. The 20 G needle also gave a larger averaged sized capsule than the 27 G 
needle. The effect of concentration of prebiotic and the protein concentration used in the 
wall material, and the needle gauge used in extrusion processing on the geometric mean 
diameter of the capsules are shown in figure 4.10. Based on an ANOVA analysis the 
main effect of needle gauge was found to have a significant effect (p<0.001) on capsule 
size, whereas all other main effects and interaction terms were not significant (p>0.05). 
The 20 G needle produced capsules with mean geometric diameters ranging between 
~2.00 to 2.30 mm (mean 2.17 ± 0.06) whereas capsules produced using the 27 G needle 
ranged in size from ~1.70 to 1.90 mm in diameter (mean 1.75 ± 0.04). Wood (2010) 
using a particle size analyzer and cryo-scanning electron microscopy reported mean 
diameters for 4.0% PPI-0.5% AL capsules of 2.0 mm and 1.5 mm respectively. The 
capsule size distribution reported by Wood also followed a non-Gaussian distribution 
which was similar to the present study. 
Typically, encapsulation by extrusion usually produces larger-type beads (0.5-














Figure 4.9 Percent distribution of capsule diameter for a 2.0% PPIc-0.5% AL-
based capsule with 1.0% prebiotics and containing probiotic bacteria 













Figure 4.10 Geometric mean diameter (mm) for PPIc-AL based capsules produced 
in the presence of B. adolescentis as a function of prebiotic levels (0, 
1.0, 2.0, 3.0%, w/w), protein concentrations (2.0, 4.0, 6.0%, w/w) and 
needle gauge (20, 27 G) used during extrusion processing. Data 






(Krasaekoopt et al., 2003). In extrusion processing capsule size is related to; a) needle 
gauge, where larger gauge needles (i.e., those with smaller inner shaft diameters) 
produces smaller capsules; b) biopolymer concentration, where higher concentrations 
(and higher viscosities) lead to the formation of larger capsules; and c) the distance 
separating the syringe from the cross-linking bath (Krasaekoopt et al., 2003; Anal and 
Singh, 2007). Sandoval-Castilla et al. (2010) investigated capsule size produced using a 
variety of AL and low-methoxy pectin mixtures, to find that with increasing total 
biopolymer concentration, capsules became bigger. Lee and Heo (2000) investigated 
different concentrations of AL (2.0, 3.0, 4.0%) on capsule size to find that with 
increased concentrations, capsule size also increased. These results are contradictory to 
the current study which found no increase in capsule size with increase in biopolymer 
concentration. In the present study, total biopolymer concentrations were raised by 
increasing the protein concentration from 2.0-6.0% which would only have a marginal 
effect on solution viscosity. However, in the case of the previous studies, only small 
increases in polysaccharide concentrations would lead to dramatic increases in solution 
viscosity.  Another major factor influencing capsule size is the diameter of the syringe 
needle used during extrusion. For instance, Muthukumarasamy et al. (2006) produced 
AL capsules with an average size of 2.37 mm using a 21 G needle, whereas Chen et al. 
(2005) using a smaller inner diameter needle (31 G needle) produced a capsules of 0.5 
mm in diameter. This was also observed in the current study, where capsules produced 
using a 20 G needle produced larger capsules (2.17 mm ± 0.06) and the 27 G needle 
produced smaller capsules (1.75 mm ± 0.04). In contrast to capsules prepared by 
emulsion-based techniques, capsules produced by extrusion tend to be more uniform in 
size. Muthukumarsamy et al. (2006) investigated the size of capsules produced by both 
emulsion and extrusion techniques using various wall materials (AL, AL + starch, 
carrageenan + locust bean gum, and xanthan + gellan) and found capsules produced via 
extrusion were much more uniform in size compared to capsules produced via emulsion. 
 
4.4.2 Protein and prebiotic retention during encapsulation 
The effect of prebiotic levels (0, 1.0, 2.0, and 3.0%, w/w), protein concentration 





retention post-encapsulation was investigated using HPAEC-PAD and the Bradford 
assay, respectively. Analyses were performed on residual levels of prebiotic and protein 
found in the cross-linking bath post-encapsulation, and then compared to original levels 
added. In the case of protein retention, nearly all of the original wall material (~99%) 
was retained within the capsule regardless of the protein concentration, prebiotic level or 
needle gauge. Reid et al. (2005) reported a similar finding for their whey protein isolate 
capsules, after extrusion through a 23 G needle and into a CaCl2 cross linking bath. The 
authors reported percent protein as measured by UV absorption at 280 nm of 99.9% 
within the capsule matrix with only 0.1% remaining within the cross linking bath. 
Rosenberg and Lee (2004) also reported high levels of protein being entrapped when 
preparing whey protein isolate capsules coated with AL. When capsules were subjected 
to either heat treatment or cross-linking, 82.6-87.5% and 78.18-83.4% of the protein was 
retained, respectively. 
The effect of protein concentration, prebiotic levels and needle gauge on capsule 
design, in terms of its ability to retain prebiotic oligosaccharides within the 
encapsulation material relative to the original amount added during the batch process (in 
percent) is given in figure 4.11. Although, slight differences in percentages of FOS 
retained were evident depending on the main treatment effects and associated 
interactions, no reliable conclusions could be drawn from the ANOVA analysis. The 
encapsulation material retained the prebiotic at levels dependent upon the original 
concentration of FOS added. For instances, the addition of 3.0 % w/w FOS (i.e., 0.57 g 
total weight added to the biopolymer mixture) led to a capsule retention of 0.081 g ± 
0.016 FOS, whereas the addition of 1.0% w/w FOS (i.e., 0.19 g total weight added to the 
biopolymer mixture) led to a retention of only 0.026 g ± 0.005 FOS. However, when 
considering equivalent batch weights, the needle gauge influenced the number of 
capsules produced, and thus the amount of FOS entrapped within an individual capsule. 
As an example, the number of capsules per gram was counted for a 2.0% (w/w) PPIn-
0.5% (w/w) AL wall material produced with 20 and 27 G needles. In the case of the 
former, 145.0 ± 6.11 capsules were formed per gram versus 436.67 ± 7.64 capsules per 
gram produced by the 27 G needle. Findings suggest that higher levels of prebiotic are 













Figure 4.11 The percentage of prebiotic retained within PPIc-AL based capsules 
post-encapsulation, produced without B. adolescentis as a function of 
prebiotic levels (0, 1.0, 2.0, 3.0%, w/w), protein concentrations (2.0, 4.0, 
6.0%, w/w) and needle gauge (20, 27 G) used during extrusion 
processing. Data represents the mean value ± one standard deviation 





similar entrapment efficiencies of FOS at 13.41%, 10.87%, and 16.83% for AL, PPI-
AL, and WPI-AL capsules, respectively. 
 
4.4.3 Swelling behaviour of capsules within simulated gastric juice 
The effect of protein concentration, prebiotic levels and needle gauge on capsule 
design was investigated in terms of their swelling behaviour (as described by the 
swelling ratio) after being immersed for 2 h in SGJ at 37°C (Figure 4.12). The negative 
swelling ratios suggest that the capsules were shrinking (have reduced volume by 
weight) or partially degrading (losing wall material into environment) over the 2 h 
duration. In the case of capsule shrinking, an osmotic gradient might have developed 
across the capsule wall leading to the migration of water out of the capsule leading to 
shrinkage. 
An ANOVA analysis found that the main effect of protein concentration on the 
swelling ratio highly significant (p<0.001), whereas all other main effects and associated 
interactions were not  significant (p>0.05).Figure 4.13 gives swelling ratios for the PPIc-
AL based capsules as a function of protein concentrations used pooled data from Figure 
4.14. Overall, swelling ratios increased (less negative) as protein levels were raised from 
2.0 to 6.0% (w/w) (or swelling became less  negative as protein concentrations increased 
in the wall material) (Figure 4.13). In the present study, it is hypothesized that a greater 
amount of intra- and intermolecular interactions are occurring between PPIc-PPIc and 
PPIc-AL at the 6.0% (w/w) level relative to the 2.0% (w/w) level since the total 
biopolymer concentration is greater despite having a capsule size that remains relatively 
constant. It is presumed the higher levels of biopolymers present would lead to more 
dense capsules that retain greater hydration. As such, this may resist capsule shrinking 
due to osmotic effects or partial degradation. Gunasekaran et al. (2007) investigated the 
effect of protein concentration on swelling behaviour of whey protein concentrate 
hydrogels heated isothermally at 80°C. They observed increased swelling with lower 
concentrations of whey protein. The authors also reported that at the higher 
















Figure 4.12 The swelling behaviour of PPIc-AL based capsules immersed in SGJ at 
37oC for 2 h. PPIc-AL based capsules were prepared with differing 
prebiotic levels (0, 1.0, 2.0, 3.0%, w/w), protein concentrations (2.0, 4.0, 
6.0%, w/w) and needle gauges (20, 27 G) used during extrusion 
processing. Data represents the mean value ± one standard deviation 











Figure 4.13 The swelling behaviour of PPIc-AL based capsules immersion in SGJ 
at 37oC for 2 h prepared without B. adolescentis and as a function 
protein concentration (2.0, 4.0, 6.0%, w/w). Data shown in this plot 
represent pooled data from Figure 4.12 based on an ANOVA analyses. 





4.4.4 Survival of free and entrapped B. adolescentis within simulated gastric juice 
The effect of protein concentration, prebiotic levels, and needle gauge on the 
survival of free and entrapped B. adolescentis within SGJ, pH adjusted to pH 2.0 was 
investigated. Overall, all capsule designs, regardless of the protein or prebiotic 
concentration added to the wall, or the needle gauge used during extrusion provided 
highly effective protection to the bacteria over 2 h duration of exposure to SGJ (Figure 
4.14). As indicated by a less than 1.5 log reduction in viable cell numbers. In contrast, 
all free cells were lost within the first 25 min of immersion in SGJ (D-value 1.44) 
(Figure 4.14a). Kotikalapudi et al. (2010) using a PPI-AL capsule to entrap 
Lactobacillus acidophilus also reported a significant protective effect of the capsules 
versus free cells. Wood (2010) entrapped B. adolescentis within AL, PPI-AL, and WPI-
AL capsules produced via extrusion and emulsion-based techniques. Survival within 
SGJ at pH 2.00 was similar to free cells for all materials in capsules produced by 
emulsion-based processes (size ranging between 10 and 350 µm). However, both PPI-
AL and WPI-AL based capsules produced by extrusion (size ranging between 2.0 and 
2.3 mm) showed significantly improve protection versus free cells, which died off 
within the first 10 min. AL capsules produced by extrusion showed no protective effect. 
Lee and Heo (2000) reported that large AL capsules (2.62 mm) provided better 
protection to B. longum cells within SGJ (pH 1.55) over a 3 h incubation period at 37°C 
compared to smaller capsules (1.03 mm). Muthukumarasamy et al. (2006) also reported 
larger AL capsules increased survival of probiotics  in SGJ. The authors compared two 
methods for encapsulation of probiotics, extrusion and emulsion techniques, and found 
that encapsulation using AL and AL plus starch via extrusion produced significantly 
larger capsules (2.0-4.0 mm) compared to emulsified capsules (20 µm to 1.0 mm); and 
reported that the larger capsules were better able to protect Lactobacillus reuteri against 
SGJ. Truelstrup-Hansen et al. (2002) reported capsules of much smaller size (20 and 70 
µm) produced via emulsification techniques did not improve survival of Bifidobacteria 
compared to free cells in SGJ. 
The addition of prebiotics to the PPIc-AL capsules in the present study did not 






Figure 4.14 Survival of free and entrapped B. adolescentis within various PPIc-AL 
based capsule designs, testing the effect of protein concentration 
(2.0%- a, b; 4.0%- c, d; 6.0%- e, f), prebiotics levels (0, 1.0, 2.0, 3.0% 
FOS) and needle gauge (20 G- left; 27 G- right). Data represents the 





study, designed capsules without FOS provided sufficient protection preventing the 
effects of FOS addition from being observed. Bielecka et al. (2002) demonstrated that  
prebiotics and probiotics administered to rats in a synbiot form showed a greater 
bifidogenic effect compared to probiotics administered alone. These results would 
indicate the administration of an encapsulated synbiot should also prove to provide 
better protection of probiotics though gastrointestinal conditions. Wood (2010) reported 
the addition of 1.0% FOS to PPI-AL capsules containing B. adolescentis improved 
survival within SGJ at pH 2.0 and 37°C. The enhanced protective nature was attributed 
to the prebiotic increasing the walls ability to limit SGJ diffusion into the capsule. Chen 
et al. (2005) also reported an increase in survival of probiotic bacteria in SGJ when 
encapsulated with a prebiotic source. The authors produced capsules via extrusion 
containing 4.0% (v/v) probiotics (1.0% of each L. acidophilus, L. casei, B. bifidum, and 
B. longum), 1.0-3.0% AL, 0-3.0% prebiotics (FOS and isomaltooliosaccharides), and 0-
1.0% peptides (pancreatic digested casein). Chen et al. reported that the addition of 
3.0% FOS to 1.0% AL and 1.0% peptides provided optimal encapsulation of probiotics 
and improved survival of probiotics in SGJ (pH 2.0) over a 1 h test period relative to 
those without FOS. Iyer and Kailasapathy (2005) tested the survival of two 
Lactobacillus acidophilus spp. (CSCC 2400 or CSCC 2409) co-encapsulated with 
prebiotic (Raftiline®ST, Raftilose®P95, or Hi-maize™) in AL capsule prepared using an 
Inotech Encapsulator®. They reported that Lactobacillus acidophilus spp. co-
encapsulated with Hi-maize starch had a heighten survival rate after exposure to acid 
conditions (pH 2.0) over a 3 h period compared to the free cells, encapsulated cells 
(without prebiotics), and those co-encapsulated with Raftiline ®ST and Raftilose®P95. 
The authors report the improved survival of L. acidophilus co-encapsulated with Hi-
maize is due to the Hi-maize blocking the pores of the capsule, thereby preventing 
diffusion of SGJ into the capsule. 
 
4.4.5 Release studies of B. adolescentis within simulated intestinal fluids 
Release within SIF at pH 6.5 at 37°C under anaerobic conditions was 
investigated over a 3 h duration. Capsule designs containing 2.0% and 6.0% PPIc-AL 





extreme formulations tested during the capsule design and survival experiments. 
Overall, all capsule designs had an initial burst release of ~5.5 log CFU/mL at time zero 
and then a more gradual release, reaching ~7 log CFU/mL within the SIF after ~1.5 h. 
For all of the capsule designs, release of bacterial cells was shown to have similar 
behaviour (Figure 4.15). Survival of free cells suggests that once released, B. 
adolescentis will be able to survive the SIF conditions. Release of the bacteria is thought 
to follow two possible mechanisms. The addition of NaHCO3 in SIF could act as a 
destabilizing agent. Sodium (Na+) is an anti-gelling cation, that when present at high 
concentrations has been shown to destabilize the AL matrix (Smidsrod and Skjakbraek, 
1990). Secondly, proteases present within the SIF are also thought help breakdown the 
capsule by degrading the PPIc within the wall material to release the cells into the 
medium. 
Many studies have investigated the release of encapsulated probiotics within SIF (Rao et 
al., 1989; Cui et al., 2000; Krasaekoopt et al., 2004). Cui et al. (2000) found the release 
of B. bifidum from AL-poly-l-lysine capsules with SIF to reach 108 CFU/g within 8 h, 
with full release (log 109-1010 CFU/g) occurring after 12 h of exposure. Rao et al. (1989) 
reported complete dissolution of capsules prepared with cellulose acetate phthalate by 
phase separation techniques and release of B. pseudolongum (109 CFU/g) within 20-40 
min of being subjected to SIF. 
 
4.4.6 Summary 
 In summary, capsule design (i.e., protein concentration, prebiotic levels 
and needle gauge used in extrusion) showed similar results in terms of their ability to 
protect B. adolescentis under SGJ conditions, and then showed release under simulated 
intestinal conditions. Release of B. adolescentis from the capsule was presumably 
caused by enzymatic degradation of the PPIc within the capsule wall from proteases or 
excess Na+ in SIF. Capsule size was found to be influenced only by the needle gauge 
used in extrusion processing, whereby the 27 G needle produced slightly smaller 
capsules than the 20 G needle. Capsules, depending on the protein concentration used 
underwent shrinking under SGJ; however this did not translate into reduced survival 












Figure 4.15 Release of entrapped B. adolescentis from within PPIc-AL based 
capsules over time (h) after being immerged within SIF at 37°C. 
Capsules designs tested included those with 2.0% and 6.0% PPIc with 
(3.0%) and without prebiotics (FOS), and compared to free cells. All 
capsules germinated using 20 G needle. Data represents the mean 








The overall goal of this research was to develop a plant protein-based capsule, 
using phase separation as a means to tailor the wall material, which would offer 
protection to B. adolescentis under simulated gastric conditions while also releasing the 
probiotic-prebiotic synbiot under simulated intestinal conditions. In the initial study, the 
effect of biopolymer and solvent conditions on phase separation was investigated for 
mixtures of pea protein isolate (PPI) and alginate (AL) to identify conditions where 
associative and segregative phase separation occurred. The resulting biopolymer mixture 
would constitute the wall material for the capsule design. Both the biopolymer mixing 
ratio and pH greatly affected associative phase separation. Critical structure forming 
events (pHc, pHφ1, pHopt) were found to shift towards higher pH values as the PPI-AL 
mixing ratios increased up to mixing ratios between 4:1 and 8:1 after which, critical pH 
values became independent of biopolymer mixing ratios up to 20:1 and resembled those 
of homogenous PPI solutions. Associative phase separation of PPIn-AL was found to be 
optimal at a biopolymer mixing ratio of 4:1, with maximum interactions occurring at pH 
2.75 ± 0.05. Similar trends were also found with electrophoretic mobility measurements 
where net neutrality shifted towards higher pH as the biopolymer mixing ratio increased 
to an 8:1, mixing ratio after which the pH corresponding to net neutrality remained 
relatively constant up to a 20:1 mixing ratio. In contrast segregative phase separation 
within the biopolymer mixtures was found to occur for these same mixing ratios at 
solvent pH >~5.00. The acidic pH required for optimal associative interactions 
prevented associative phase separation from being used for encapsulation of the 
probiotic bacteria, which have optimal growth at neutral pH (pH 6.00-7.00).   
Due to the harsh conditions required for optimal associative phase separation to 
occur, two capsules designs were developed using segregative phase separation in the 
presence of calcium for the entrapment of the probiotic bacteria.  PPI-AL capsules were 
designed using both a native PPI (PPIn) and commercial PPI (PPIc). PPIn and PPIc 
capsules with entrapped B. adolescentis were effective at protecting the probiotic 





at 108-109 CFU/mL through the 2 h period where as the free cells experienced a rapid 
decline in numbers after the first 10 min within the SGJ. 
The use of the commercial PPI in capsule design was further investigated as it 
will be easier for scale-up within industry compared to using the ‘native-form’ of the 
PPI. Capsule performance was investigated as a function of protein concentration (2.0, 
4.0, and 6.0%, w/w), prebiotic level (0, 1.0, 2.0, and 3.0%, FOS w/w), and extrusion 
conditions (20 vs. 27 gauge needle) in order to optimize (for parameters tested) the 
capsules protective ability for B. adolescentis against SGJ and release within SIF. The 
capsule designs showed similar results in terms of their ability to protect B. adolescentis 
within the SGJ. The capsules also revealed release within SIF, which was presumed to 
be due to enzymatic degradation of the PPIc capsule wall and/or due to the excess 
amount of Na+ present in the medium (Smidsrod and Skjakbraek, 1990). The capsules 
retained nearly all of the protein added, where the concentration of prebiotics added was 
dependent on the amount initially added to the capsule. Larger capsules were able to 
entrap more FOS per capsule compared to the smaller ones. The capsule size was 
influenced by the needle gauge, where a 20 G needle produced larger capsules (2.17 ± 
0.06) compared to the 27 G needle (1.75 ± 0.04). The capsules were also found to shrink 
when subjected to SGJ, with high protein rates slowing shrinkage. Although the 
capsules shrank, this did not affect the ability of the capsule to protect the B. 
adolescentis in SGJ. Based on research performed the overall optimized capsule design 
to move forward would be 2.0% PPIc-0.5% AL without FOS and extruded through a 20 
G needle. These capsules provided sufficient protection and release of the probiotic 
bacteria when subjected to challenge experiments. The 2.0% PPIc would allow for less 
protein to be used and therefore would reduce the cost of the capsule during production. 
A 20 G needle during processing would allow for easier production of the capsules and 
produced only a minimal increase in size compared to the 27 G needle. In the current 
research prebiotics did not enhance the protective ability of the capsule for B. 
adolescentis during challenge experiments. However, no studies were performed on the 
release of the prebiotic within the colon. It is hypothesized that the added FOS to the 
capsules could improve colonization of the bacteria once reaching the colon and 





warranted to better evaluate the benefit of FOS inclusion and targeted synbiot delivery. 
Based on capsule size (~2 mm in diameter), developed capsules would be unsuitable for 
the human food market, however based on their size they may be more appropriate for 






6. Future Directions 
This study revealed that PPI-AL capsules produced via extrusion can provide 2 h 
protection for the probiotic bacteria, B. adolescentis ATCC 15703 in SGJ at pH 2.0 
regardless of capsule parameters and then be released over the course of 3 h within SIF 
at pH 6.5. Swelling tests also revealed shrinking of the capsules in SGJ at pH 2.0 
suggesting either physical degradation of the capsule or passive diffusion of water out of 
the capsule. Using microscopy to examine the structure during these swelling 
experiments as well as during degradation of the capsule in SIF (pH 6.5) might give a 
better understanding of how the capsules release the prebiotics and probiotics. 
A synbiot was successfully produced by entrapping B. adolescentis and the 
prebiotic FOS within the PPI-AL capsule. The added FOS did not influence the ability 
of the capsule to protect the probiotic bacteria when subjected to gastric challenge 
experiments. Once into the intestine capsule breaks down and releases probiotic. The 
bacteria are then exposed to acid and bile salt causing the cells to be in a stressed state. 
The added prebiotic source could provide an accessible carbon source in the colon 
giving the probiotic bacteria a competitive advantage during adhesion to the intestinal 
wall. No studies were performed on release of the FOS in SIF. As well as, no studies 
were done to determine performance of the capsules or entrapped synbiots during 
sequential transit through the stomach, small intestine and colon conditions. A simulator 
of the human intestinal microbial ecosystem (SHIME) could provide valuable 
information on the ability of the capsule to move sequentially through gastrointestinal 
conditions as well as determine if the added FOS provides a useful carbon source once 
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